Article(id=1198656215766102871, tenantId=1146029695717560320, journalId=1189982191388893191, issueId=1198656209390764948, articleNumber=null, orderNo=null, doi=10.16438/j.0513-4870.2023-0008, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1672848000000, receivedDateStr=2023-01-05, revisedDate=1680537600000, revisedDateStr=2023-04-04, acceptedDate=null, acceptedDateStr=null, onlineDate=1763711511794, onlineDateStr=2025-11-21, pubDate=1697040000000, pubDateStr=2023-10-12, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1763711511794, onlineIssueDateStr=2025-11-21, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1763711511794, creator=13701087609, updateTime=1763711511794, updator=13701087609, issue=Issue{id=1198656209390764948, tenantId=1146029695717560320, journalId=1189982191388893191, year='2023', volume='58', issue='10', pageStart='2835', pageEnd='3150', issueExtLink='null', onlineDate='null', pubDate='1697040000000', pubDateStr='2023-10-12', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1763711510274, creator='13701087609', updateTime=1763711659007, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1198656833280897539, tenantId=1146029695717560320, journalId=1189982191388893191, issueId=1198656209390764948, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1198656833280897540, tenantId=1146029695717560320, journalId=1189982191388893191, issueId=1198656209390764948, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=2862, endPage=2874, ext={EN=ArticleExt(id=1198656216139395936, articleId=1198656215766102871, tenantId=1146029695717560320, journalId=1189982191388893191, language=EN, title=Rapid identification of chemical constituents in Xuezhikang Capsule by UPLC-Q-TOF/MSE combined with the establishment of UNIFI MS database, columnId=null, journalTitle=Acta Pharmaceutica Sinica, columnName=null, runingTitle=null, highlight=null, articleAbstract=

An UPLC-Q-TOF/MSE technology coupled with UNIFI database was used to develop a rapid, high coverage, accurate and efficient chemical composition qualitative method for Xuezhikang Capsule. A UNIFI database was established utilizing compound name, formula, structure, following automatic matching with high-resolution mass numbers, isotope distributions, mass deviations, fragment ion matching, and chromatographic retention features in UNIFI database to achieve the qualitative results of natural products in Xuezhikang Capsules. Combined with manual confirmation, 82 chemical components were identified in Xuezhikang Capsules, and the MS2 fragmentation pathway of typical organic acids, flavonoids, monacrines, and monascus were analyzed to ensure accuracy of the LC-MS workflow. This study clarified the chemical substance basis of Xuezhikang Capsules by LC-MS technology, providing experimental data support for the identification of key quality attributes, quality control and consistency evaluation in the manufacturing process of Xuezhikang Capsules.

, authors=null, authorsList=Guo-fang TIAN, Lan XUE, Xi LIU, Huan PEI, Yu TANG, authorCompany=null, correspAuthors=Yu TANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=Copyright ©2023 Acta Pharmaceutica Sinica. All rights reserved., copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1198656219494839227, articleId=1198656215766102871, tenantId=1146029695717560320, journalId=1189982191388893191, language=CN, title=基于UPLC-Q-TOF/MSE的UNIFI质谱数据库建立及其在血脂康胶囊化学成分的快速分析中的应用, columnId=1198656210498061206, journalTitle=药学学报, columnName=专题报道: 中药制造质量控制与智能制造, runingTitle=null, highlight=null, articleAbstract=

本研究采用UPLC-Q-TOF/MSE技术结合UNIFI数据库开发了快速、全面、准确、高效的血脂康胶囊化学成分定性分析方法。利用化合物名称、分子量、分子式、结构式等信息建立UNIFI数据库, 并依据高分辨质量数、同位素分布、质量偏差、碎片离子匹配度、色谱保留行为等信息进行数据库自动检索, 实现药材和制剂中天然产物的定性鉴定。结合手动确证, 在血脂康胶囊及红曲药材中鉴定到82种化学成分, 对于其中的有机酸类、黄酮类、莫纳克林类、红曲色素类主要成分进行了质谱裂解规律分析, 确保鉴定准确度, 多种莫纳可林类化合物为首次采用LC-MS工作流程实现定性分析。综上, 本研究通过LC-MS技术阐明了血脂康胶囊的化学物质基础, 为血脂康胶囊中药制造过程中的关键质量属性控制和一致性评价提供了扎实的实验数据支持, 为基于血脂康胶囊的药效物质基础研究提供支撑。

, authors=null, authorsList=田国芳, 薛岚, 刘曦, 裴欢, 唐煜, authorCompany=null, correspAuthors=唐煜, authorNote=null, correspAuthorsNote=
*唐煜, Tel: 86-10-62795450, E-mail:
, copyrightStatement=版权所有©《药学学报》编辑部2023, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=0lvAu3bBsa8q6K95ijC0jg==, magXml=Hx5GillmM/CzJYAJpx5C2g==, pdfUrl=null, pdf=G5cVUZ8yHLJy1i781YlVWA==, pdfFileSize=1668950, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=yRSW/jqBQYMlZTcI5yedlw==, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=nvRxnPPd6P7uhal6DY9H7w==, mapNumber=null, fund=null)}, authors=[Author(id=1198960239757329318, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1198960240000598970, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960239757329318, language=EN, stringName=Guo-fang TIAN, firstName=Guo-fang, middleName=null, lastName=TIAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1. Center of Pharmaceutical Technology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1198960240143205321, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960239757329318, language=CN, stringName=田国芳, firstName=国芳, middleName=null, lastName=田, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.清华大学药学院, 清华大学药学技术中心, 北京 100084, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1198960239337898869, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, xref=null, ext=[AuthorCompanyExt(id=1198960239346287480, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239337898869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. Center of Pharmaceutical Technology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China), AuthorCompanyExt(id=1198960239371453306, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239337898869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.清华大学药学院, 清华大学药学技术中心, 北京 100084)])]), Author(id=1198960240290005981, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1198960240445195250, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960240290005981, language=EN, stringName=Lan XUE, firstName=Lan, middleName=null, lastName=XUE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1198960240558440452, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960240290005981, language=CN, stringName=薛岚, firstName=岚, middleName=null, lastName=薛, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.北京北大维信生物科技有限公司, 北京 100083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1198960239556002700, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, xref=null, ext=[AuthorCompanyExt(id=1198960239572779919, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China), AuthorCompanyExt(id=1198960239585362833, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.北京北大维信生物科技有限公司, 北京 100083)])]), Author(id=1198960240650715153, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1198960240784932894, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960240650715153, language=EN, stringName=Xi LIU, firstName=Xi, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1198960240923344936, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960240650715153, language=CN, stringName=刘曦, firstName=曦, middleName=null, lastName=刘, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.北京北大维信生物科技有限公司, 北京 100083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1198960239556002700, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, xref=null, ext=[AuthorCompanyExt(id=1198960239572779919, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China), AuthorCompanyExt(id=1198960239585362833, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.北京北大维信生物科技有限公司, 北京 100083)])]), Author(id=1198960241091117114, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1198960241225334851, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960241091117114, language=EN, stringName=Huan PEI, firstName=Huan, middleName=null, lastName=PEI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1198960241309220942, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960241091117114, language=CN, stringName=裴欢, firstName=欢, middleName=null, lastName=裴, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.北京北大维信生物科技有限公司, 北京 100083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1198960239556002700, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, xref=null, ext=[AuthorCompanyExt(id=1198960239572779919, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China), AuthorCompanyExt(id=1198960239585362833, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.北京北大维信生物科技有限公司, 北京 100083)])]), Author(id=1198960241414078555, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=tangyu@tsinghua.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1198960241535713386, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960241414078555, language=EN, stringName=Yu TANG, firstName=Yu, middleName=null, lastName=TANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1. Center of Pharmaceutical Technology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1198960241707679864, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960241414078555, language=CN, stringName=唐煜, firstName=煜, middleName=null, lastName=唐, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.清华大学药学院, 清华大学药学技术中心, 北京 100084, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1198960239337898869, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, xref=null, ext=[AuthorCompanyExt(id=1198960239346287480, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239337898869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. Center of Pharmaceutical Technology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China), AuthorCompanyExt(id=1198960239371453306, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239337898869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.清华大学药学院, 清华大学药学技术中心, 北京 100084)])])], keywords=[Keyword(id=1198960241971921046, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, orderNo=1, keyword=UPLC-Q-TOF), Keyword(id=1198960242122916002, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, orderNo=2, keyword=MSE), Keyword(id=1198960242265522352, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, orderNo=3, keyword=UNIFI database), Keyword(id=1198960242424905916, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, orderNo=4, keyword=Xuezhikang Capsule), Keyword(id=1198960242575900878, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, orderNo=5, keyword=analytical method development), Keyword(id=1198960242731090151, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, orderNo=1, keyword=UPLC-Q-TOF), Keyword(id=1198960242861113592, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, orderNo=2, keyword=MSE), Keyword(id=1198960242970165511, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, orderNo=3, keyword=UNIFI数据库), Keyword(id=1198960243112771861, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, orderNo=4, keyword=血脂康胶囊), Keyword(id=1198960243217629475, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, orderNo=5, keyword=分析方法开发)], refs=[Reference(id=1198960246594044553, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2011, volume=46, issue=null, pageStart=564, pageEnd=567, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=Li XM, Shen XH, Duan ZW, journalName=Acta Pharm Sin (药学学报), refType=null, unstructuredReference= Li XM , Shen XH , Duan ZW , et al . A new monacolin analogue from Xuezhikang Capsule[J]. Acta Pharm Sin (药学学报), 2011, 46: 564-567., articleTitle=A new monacolin analogue from Xuezhikang Capsule, refAbstract=null), Reference(id=1198960246766011029, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2007, volume=38, issue=null, pageStart=650, pageEnd=652, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=Ma XM, Guo SR, Duan ZW, journalName=Chin Tradit Herb Drugs (中草药), refType=null, unstructuredReference= Ma XM , Guo SR , Duan ZW , et al . Chemical constituents of Xuezhikang Capsula[J]. Chin Tradit Herb Drugs (中草药), 2007, 38: 650-652., articleTitle=Chemical constituents of Xuezhikang Capsula, refAbstract=null), Reference(id=1198960246883451548, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2022, volume=37, issue=null, pageStart=2276, pageEnd=2280, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=Li J, Zhu Y, Wang K, journalName=Drugs Clin (现代药物与临床), refType=null, unstructuredReference= Li J , Zhu Y , Wang K . Clinical study on Xuezhikang Capsules combined with pravastatin in treatment of chronic heart failure[J]. Drugs Clin (现代药物与临床), 2022, 37: 2276-2280., articleTitle=Clinical study on Xuezhikang Capsules combined with pravastatin in treatment of chronic heart failure, refAbstract=null), Reference(id=1198960246992503463, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2021, volume=52, issue=null, pageStart=1092, pageEnd=1104, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=Meng TT, Xie XL, Li TT, journalName=Chin Tradit Herb Drugs (中草药), refType=null, unstructuredReference= Meng TT , Xie XL , Li TT , et al . Oral Chinese patent medicine combined with statins in treatment of dyslipidemia: a network meta-analysis[J]. Chin Tradit Herb Drugs (中草药), 2021, 52: 1092-1104., articleTitle=Oral Chinese patent medicine combined with statins in treatment of dyslipidemia: a network meta-analysis, refAbstract=null), Reference(id=1198960247130915507, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2022, volume=40, issue=null, pageStart=180, pageEnd=183, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=Ye F, Yu ZH, Yang JH, journalName=Chin Arch Tradit Chin Med (中华中医药学刊), refType=null, unstructuredReference= Ye F , Yu ZH , Yang JH , et al . Effect of Xuezhikang Capsule in treatment of coronary heart disease and its influence on vascular endothelial function and heart function[J]. Chin Arch Tradit Chin Med (中华中医药学刊), 2022, 40: 180-183., articleTitle=Effect of Xuezhikang Capsule in treatment of coronary heart disease and its influence on vascular endothelial function and heart function, refAbstract=null), Reference(id=1198960247248356032, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2007, volume=48, issue=null, pageStart=992, pageEnd=993, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=Zhou K, Ding BH, journalName=J Tradit Chin Med (中医杂志), refType=null, unstructuredReference= Zhou K , Ding BH . Clinical observation on Xuezhikang Capsule for 116 cases of coronary heart disease with abnormal blood lipid[J]. J Tradit Chin Med (中医杂志), 2007, 48: 992-993., articleTitle=Clinical observation on Xuezhikang Capsule for 116 cases of coronary heart disease with abnormal blood lipid, refAbstract=null), Reference(id=1198960247395156685, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2008, volume=49, issue=null, pageStart=1019, pageEnd=1022, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=Yang Z, Zhao JX, Zhang YG, journalName=J Tradit Chin Med (中医杂志), refType=null, unstructuredReference= Yang Z , Zhao JX , Zhang YG . Anti-neoplastic effect of Xuezhikang in vitro[J]. J Tradit Chin Med (中医杂志), 2008, 49: 1019-1022., articleTitle=Anti-neoplastic effect of Xuezhikang in vitro, refAbstract=null), Reference(id=1198960247541957337, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2011, volume=11, issue=null, pageStart=2289, pageEnd=2291, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=Li B, Hu SY, Wu X, journalName=Prog Mod Biomed (现代生物医学进展), refType=null, unstructuredReference= Li B , Hu SY , Wu X , et al . Anti-oxidant and anti-inflammatory effects of Xuezhikang capsule on patients with coronary heart diseases[J]. Prog Mod Biomed (现代生物医学进展), 2011, 11: 2289-2291., articleTitle=Anti-oxidant and anti-inflammatory effects of Xuezhikang capsule on patients with coronary heart diseases, refAbstract=null), Reference(id=1198960247692952298, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2021, volume=52, issue=null, pageStart=7379, pageEnd=7388, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=Jiang YQ, Dong YJ, Zhou FJ, journalName=Chin Tradit Herb Drugs (中草药), refType=null, unstructuredReference= Jiang YQ , Dong YJ , Zhou FJ , et al . Research progress on chemical constituents, pharmacological action and clinical application of Fermentum Rubrum[J]. Chin Tradit Herb Drugs (中草药), 2021, 52: 7379-7388., articleTitle=Research progress on chemical constituents, pharmacological action and clinical application of Fermentum Rubrum, refAbstract=null), Reference(id=1198960247810392823, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=10.1002/jssc.201900737, pmid=null, pmcid=null, year=2020, volume=43, issue=null, pageStart=31, pageEnd=55, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=Tang Y, Zhang JL, journalName=J Sep Sci, refType=null, unstructuredReference= Tang Y , Zhang JL . Recent developments in DNA adduct analysis using liquid chromatography coupled with mass spectrometry[J]. J Sep Sci, 2020, 43: 31-55., articleTitle=Recent developments in DNA adduct analysis using liquid chromatography coupled with mass spectrometry, refAbstract=null), Reference(id=1198960247948804871, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=10.1021/acs.analchem.8b05405, pmid=null, pmcid=null, year=2019, volume=91, issue=null, pageStart=5629, pageEnd=5637, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=Ji H, Xu Y, Lu H, journalName=Anal Chem, refType=null, unstructuredReference= Ji H , Xu Y , Lu H , et al . Deep MS/MS-aided structural-similarity scoring for unknown metabolite identification[J]. Anal Chem, 2019, 91: 5629-5637., articleTitle=Deep MS/MS-aided structural-similarity scoring for unknown metabolite identification, refAbstract=null), Reference(id=1198960248112382741, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=10.1016/j.talanta.2020.121500, pmid=null, pmcid=null, year=2021, volume=222, issue=null, pageStart=121500, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=Tang Y, Chen X, Wang D, journalName=Talanta, refType=null, unstructuredReference= Tang Y , Chen X , Wang D , et al . Discover and identify unknown alkylation DNA adducts induced by sulfonates using prediction driven-MRM-profiling strategy[J]. Talanta, 2021, 222: 121500., articleTitle=Discover and identify unknown alkylation DNA adducts induced by sulfonates using prediction driven-MRM-profiling strategy, refAbstract=null), Reference(id=1198960248280154911, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2020, volume=43, issue=null, pageStart=1997, pageEnd=2008, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=Yuan FL, Liu CX, Wang Q, journalName=Drug Eval Res (药物评价研究), refType=null, unstructuredReference= Yuan FL , Liu CX , Wang Q , et al . Rapid detection and identification of compounds in Jiuwei Zhenxin Granules based on UPLC-Q-TOF/MSE and UNIFI software[J]. Drug Eval Res (药物评价研究), 2020, 43: 1997-2008., articleTitle=Rapid detection and identification of compounds in Jiuwei Zhenxin Granules based on UPLC-Q-TOF/MSE and UNIFI software, refAbstract=null), Reference(id=1198960248502453042, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2017, volume=38, issue=null, pageStart=75, pageEnd=82, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=Wang ML, Zhang QQ, Fu S, journalName=J Chin Mass Spectrom Soc (质谱学报), refType=null, unstructuredReference= Wang ML , Zhang QQ , Fu S , et al . Characterization of Morinda officinalis How. by UPLC-Q-TOF MSE coupled with UNIFI database filter[J]. J Chin Mass Spectrom Soc (质谱学报), 2017, 38: 75-82., articleTitle=Characterization of Morinda officinalis How. by UPLC-Q-TOF MSE coupled with UNIFI database filter, refAbstract=null), Reference(id=1198960248678613826, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2020, volume=32, issue=null, pageStart=498, pageEnd=506, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=Wu H, Tang MX, Tao XY, journalName=Nat Prod Res Dev (天然产物研究与开发), refType=null, unstructuredReference= Wu H , Tang MX , Tao XY , et al . Rapid identification of chemical consituents in cinobufacini injection by UPLC-ESI-QTOF/MSE combined with UNIFI informatics platform[J]. Nat Prod Res Dev (天然产物研究与开发), 2020, 32: 498-506., articleTitle=Rapid identification of chemical consituents in cinobufacini injection by UPLC-ESI-QTOF/MSE combined with UNIFI informatics platform, refAbstract=null), Reference(id=1198960248821220177, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=10.1016/j.jpba.2004.04.004, pmid=null, pmcid=null, year=2004, volume=35, issue=null, pageStart=1101, pageEnd=1112, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=Li YG, Zhang F, Wang ZT, journalName=J Pharm Biomed Anal, refType=null, unstructuredReference= Li YG , Zhang F , Wang ZT , et al . Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry[J]. J Pharm Biomed Anal, 2004, 35: 1101-1112., articleTitle=Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry, refAbstract=null), Reference(id=1198960248947049307, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2011, volume=42, issue=null, pageStart=1018, pageEnd=1025, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=Li XM, Shen XH, Duan ZW, journalName=Chin Tradit Herb Drugs (中草药), refType=null, unstructuredReference= Li XM , Shen XH , Duan ZW , et al . Advances in studies on secondary metabolites from Monascus[J]. Chin Tradit Herb Drugs (中草药), 2011, 42: 1018-1025., articleTitle=Advances in studies on secondary metabolites from Monascus, refAbstract=null), Reference(id=1198960249085461355, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2021, volume=56, issue=null, pageStart=913, pageEnd=923, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=Li XP, Yu MX, Kuang RT, journalName=Acta Pharm Sin (药学学报), refType=null, unstructuredReference= Li XP , Yu MX , Kuang RT , et al . Research progress on the anti-tumor effect of flavonoid derivatives[J]. Acta Pharm Sin (药学学报), 2021, 56: 913-923., articleTitle=Research progress on the anti-tumor effect of flavonoid derivatives, refAbstract=null), Reference(id=1198960249223873401, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2018, volume=39, issue=null, pageStart=729, pageEnd=745, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=Ding YT, Zheng ZH, Zhao RY, journalName=J Chin Mass Spectrom Soc (质谱学报), refType=null, unstructuredReference= Ding YT , Zheng ZH , Zhao RY , et al . Rapid identification of chemical constituents in Psoralea coryifolia by UPLC-Q-TOF-MSE combined with UNIFI informatics platform[J]. J Chin Mass Spectrom Soc (质谱学报), 2018, 39: 729-745., articleTitle=Rapid identification of chemical constituents in Psoralea coryifolia by UPLC-Q-TOF-MSE combined with UNIFI informatics platform, refAbstract=null), Reference(id=1198960249328731012, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2016, volume=47, issue=null, pageStart=2465, pageEnd=2469, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=Yu S, Zhang L, Shan MQ, journalName=Chin Tradit Herb Drugs (中草药), refType=null, unstructuredReference= Yu S , Zhang L , Shan MQ , et al . Simultaneous determination of eight organic acids in Chaenomelis Fructus by UFLC-MS[J]. Chin Tradit Herb Drugs (中草药), 2016, 47: 2465-2469., articleTitle=Simultaneous determination of eight organic acids in Chaenomelis Fructus by UFLC-MS, refAbstract=null), Reference(id=1198960249500697494, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2022, volume=39, issue=null, pageStart=639, pageEnd=652, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=Wang YC, Dong JX, Li JG, journalName=J Shenyang Pharm Univ (沈阳药科大学学报), refType=null, unstructuredReference= Wang YC , Dong JX , Li JG , et al . Rapid analysis of chemical components of Wenjing Decoction Standard Decoction based on UPLC-Q-TOF/MS technology combined with UNIFI database[J]. J Shenyang Pharm Univ (沈阳药科大学学报), 2022, 39: 639-652., articleTitle=Rapid analysis of chemical components of Wenjing Decoction Standard Decoction based on UPLC-Q-TOF/MS technology combined with UNIFI database, refAbstract=null), Reference(id=1198960249597166503, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2012, volume=15, issue=null, pageStart=164, pageEnd=166, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=Li XM, Xue L, Fu P, journalName=China Pharm (中国药师), refType=null, unstructuredReference= Li XM , Xue L , Fu P , et al . Determination of lovastatin and lovastatin acid in Xuezhikang Capsules by HPLC[J]. China Pharm (中国药师), 2012, 15: 164-166., articleTitle=Determination of lovastatin and lovastatin acid in Xuezhikang Capsules by HPLC, refAbstract=null), Reference(id=1198960249748161463, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2019, volume=30, issue=null, pageStart=2066, pageEnd=2070, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=Li Y, Sun X, journalName=China Pharm (中国药房), refType=null, unstructuredReference= Li Y , Sun X . Simultaneous content determination of 8 components in Xuezhikang Capsules by HPLC-DAD[J]. China Pharm (中国药房), 2019, 30: 2066-2070., articleTitle=Simultaneous content determination of 8 components in Xuezhikang Capsules by HPLC-DAD, refAbstract=null), Reference(id=1198960249878184904, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, doi=null, pmid=null, pmcid=null, year=2017, volume=39, issue=null, pageStart=316, pageEnd=319, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=Tu WQ, Zhang LJ, Xu ZZ, journalName=Chin Tradit Pat Med (中成药), refType=null, unstructuredReference= Tu WQ , Zhang LJ , Xu ZZ . Simultaneous determination of three constituents in Yixin Xuezhikang Capsules by HPLC[J]. Chin Tradit Pat Med (中成药), 2017, 39: 316-319., articleTitle=Simultaneous determination of three constituents in Yixin Xuezhikang Capsules by HPLC, refAbstract=null)], funds=[Fund(id=1198960246279471731, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, awardId=null, language=CN, fundingSource=清华大学实验室创新基金, fundOrder=null, country=null)], companyList=[AuthorCompany(id=1198960239337898869, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, xref=null, ext=[AuthorCompanyExt(id=1198960239346287480, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239337898869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. Center of Pharmaceutical Technology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China), AuthorCompanyExt(id=1198960239371453306, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239337898869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.清华大学药学院, 清华大学药学技术中心, 北京 100084)]), AuthorCompany(id=1198960239556002700, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, xref=null, ext=[AuthorCompanyExt(id=1198960239572779919, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China), AuthorCompanyExt(id=1198960239585362833, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.北京北大维信生物科技有限公司, 北京 100083)])], figs=[ArticleFig(id=1198960243465093438, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, label=null, caption=null, figureFileSmall=+hwy2CQU7cLVPOFUuap4IQ==, figureFileBig=SxlRIsgPNo5adE5J7sQ+Bw==, tableContent=null), ArticleFig(id=1198960243536396621, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, label=Figure 1, caption= Optimization of different column and eluent systems. A: Cosmosil 5C18-MS-Ⅱ column with isopropanol elution system; B: Waters UPLC BEH C18 column with methanol/acetonitrile elution system; C: Waters UPLC HSS T3 column with methanol/acetonitrile elution system; D: Cosmosil 5C18-MS-Ⅱ column with methanol/acetonitrile elution system , figureFileSmall=+hwy2CQU7cLVPOFUuap4IQ==, figureFileBig=SxlRIsgPNo5adE5J7sQ+Bw==, tableContent=null), ArticleFig(id=1198960243662225754, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, label=null, caption=null, figureFileSmall=mOS3Wmon3KV4bF42jEqU1g==, figureFileBig=B5n8+8FOBppBD5pje+u4+A==, tableContent=null), ArticleFig(id=1198960243863552362, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, label=Figure 2, caption= Base peak ion chromatogram of Xuezhikang Capsula (Lot No. 20211256) testing sample analysis in ESI<sup>+</sup> (A) and ESI<sup>-</sup> (B) mode (The numbers in Figure 2 correspond to the peak No. in Table 2) , figureFileSmall=mOS3Wmon3KV4bF42jEqU1g==, figureFileBig=B5n8+8FOBppBD5pje+u4+A==, tableContent=null), ArticleFig(id=1198960243997770107, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, label=null, caption=null, figureFileSmall=bjEJtL2btJrBP7cJ/ErkfA==, figureFileBig=SewiQCbeXbcDCsq5mb+CkA==, tableContent=null), ArticleFig(id=1198960244131987855, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, label=Figure 3, caption= MS spectrum in high energy scan mode (A) and fragmentation pathway (B) of feature peak 63 in positive ion mode (▲: Precursor ion; *: Fragment ions) , figureFileSmall=bjEJtL2btJrBP7cJ/ErkfA==, figureFileBig=SewiQCbeXbcDCsq5mb+CkA==, tableContent=null), ArticleFig(id=1198960244274594203, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, label=null, caption=null, figureFileSmall=CxKp+6WfFcxIv6mSR1sIcQ==, figureFileBig=dnIhcTKishYuFcuajuXu1g==, tableContent=null), ArticleFig(id=1198960244387840430, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, label=Figure 4, caption= MS spectrum in high energy scan mode (A) and fragmentation pathway (B) of feature peak 75 in positive ion mode (▲: Precursor ion; *: Fragment ions) , figureFileSmall=CxKp+6WfFcxIv6mSR1sIcQ==, figureFileBig=dnIhcTKishYuFcuajuXu1g==, tableContent=null), ArticleFig(id=1198960244522058177, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, label=null, caption=null, figureFileSmall=rgZ9E2t7zh4Gk6H5F+YLdQ==, figureFileBig=3/sGO+fELyOrsiaHzANTJg==, tableContent=null), ArticleFig(id=1198960244622721485, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, label=Figure 5, caption= MS spectrum in high energy scan mode (A) and fragmentation pathway (B) of feature peak 40 in positive ion mode (▲: Precursor ion; *: Fragment ions) , figureFileSmall=rgZ9E2t7zh4Gk6H5F+YLdQ==, figureFileBig=3/sGO+fELyOrsiaHzANTJg==, tableContent=null), ArticleFig(id=1198960244761133537, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, label=null, caption=null, figureFileSmall=lbpWcmzM2651bXQiAUqzSw==, figureFileBig=vDnArtiFwbAFp9PF2Iz7vQ==, tableContent=null), ArticleFig(id=1198960245096677883, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, label=Figure 6, caption= MS spectrum in high energy scan mode (A) and fragmentation pathway (B) of feature peak 13 in positive ion mode (▲: Precursor ion; *: Fragment ions) , figureFileSmall=lbpWcmzM2651bXQiAUqzSw==, figureFileBig=vDnArtiFwbAFp9PF2Iz7vQ==, tableContent=null), ArticleFig(id=1198960245293810195, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, label=null, caption=null, figureFileSmall=KC2ESrXDxLZUiH9fN/+7/A==, figureFileBig=25AQOt3XIJDt8LaX7xQhXw==, tableContent=null), ArticleFig(id=1198960245402862113, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, label=Figure 7, caption= MS spectrum in high energy scan mode (A) and fragmentation pathway (B) of feature peak 58 in positive ion mode (▲: Precursor ion; *: Fragment ions) , figureFileSmall=KC2ESrXDxLZUiH9fN/+7/A==, figureFileBig=25AQOt3XIJDt8LaX7xQhXw==, tableContent=null), ArticleFig(id=1198960245574828594, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, label=null, caption=null, figureFileSmall=null, figureFileBig=null, tableContent=
No. Compound name Formula Mr/Da CAS No.
1 4-Methoxycinnamic acid C10H10O3 178.063 0 830-09-1
2 3-Hydroxy-4-methoxycinnamic acid C10H10O4 194.057 9 537-73-5
3 Ferulic acid C10H10O4 194.057 9 1135-24-6
4 Ethylenediaminetetraacetic acid C10H16N2O8 292.090 7 60-00-4
5 Lunatinin C13H14O5 250.084 1 69364-81-4
6 Daidzein C15H10O4 254.057 9 486-66-8
7 Genistein C15H10O5 270.052 8 446-72-0
8 Cianidanol C15H14O6 290.079 0 154-23-4
9 Osthole C15H16O3 244.109 9 484-12-8
10 Glycitein C16H12O5 284.068 5 40957-83-3
11 Chlorogenic acid C16H18O9 354.095 1 327-97-9
12 ML-236C C18H26O3 290.188 2 58889-18-2
13 ML-236A C18H26O4 306.183 1 58889-19-3
14 Linoleic acid C18H32O2 280.240 2 60-33-3
15 Folic acid C19H19N7O6 441.139 7 59-30-3
16 Monacolin Q C19H22O2 282.162 0 1879038-89-7
17 α, β-Hydromonacolin Q C19H24O3 300.172 5 118045-32-2
18 Dehydromonacolin L C19H26O2 286.193 3 1355394-52-3
19 Dehydromonacolin J C19H26O3 302.188 2 1355394-51-2
20 Dehydromonacolin MV2 C19H26O5 334.178 0 -
21 α, β-Dehydrodihydromonacolin L C19H28O2 288.208 9 531523-94-1
22 Monacolin R C19H28O3 304.203 8 1879038-90-0
23 Monacolin L C19H28O3 304.203 8 79394-47-1
24 Monacolin J C19H28O4 320.198 8 79952-42-4
25 Dihydromonacolin L C19H30O3 306.219 5 86827-77-2
26 3α-Hydroxy-3, 5-dihydromonacolin L C19H30O4 322.214 4 119786-66-2
27 Sterculic acid C19H34O2 294.255 9 738-87-4
28 Monacolin L acid methyl ester C20H32O4 336.230 1 312710-94-4
29 Monalbidin N5 C20H32O5 352.225 0 2769120-20-7
30 Rubropunctatine C21H22O5 354.146 7 514-67-0
31 Rubropunctamine C21H23NO4 353.162 7 514-66-9
32 Monascin C21H26O5 358.178 0 21516-68-7
33 Dehydromonacolin N C21H28O4 344.198 8 1355394-50-1
34 6-α-O-Ethyl-4, 6-dihydromonacoline L C21H34O4 350.245 7 -
35 Monacolin T C21H36O5 368.256 3 -
36 Monacolin N1 C22H34O6 394.235 5 -
37 Monacolin U C22H38O5 382.271 9 -
38 Rotiorinol A C23H26O5 382.178 0 901309-41-9
39 Monascorubrin C23H26O5 382.178 0 13283-90-4
40 Monascorubramin C23H27NO4 381.194 0 3627-51-8
41 Robustadial A C23H30O5 386.209 3 88130-99-8
42 Mevastatin C23H34O5 390.240 6 73573-88-3
43 Monacolin M C23H34O6 406.235 5 106909-04-0
44 Dehydromonacolin K C24H34O4 386.245 7 109273-98-5
45 Monacolin X C24H34O6 418.235 5 96497-73-3
46 α, β-Dehydrodihydromonacolin K C24H36O4 388.261 4 312710-92-2
47 Monacolin K C24H36O5 404.256 3 75330-75-5
48 Dihydromonacolin K C24H38O5 406.271 9 77517-29-4
49 Dehydromonacolin MV C24H38O5 406.271 9 935846-59-6
50 Lovastatin acid C24H38O6 422.266 8 77550-67-5
51 Monacolin S C24H38O7 438.261 8 -
52 Monacolin K methyl ester C25H40O6 436.282 5 77934-80-6
53 Monacolin K ethyl ester C26H42O6 450.298 1 77517-31-8
54 Ergosterol C28H44O 396.339 2 57-87-4
55 Stigmasterin C29H48O 412.370 5 83-48-7
56 Oxalic acid C2H2O4 89.995 3 144-62-7
57 Acetic acid C2H4O2 60.021 1 64-19-7
58 Glycolic acid C2H4O3 76.016 0 79-14-1
59 β-Glycyrrhetinic acid C30H46O4 470.339 6 471-53-4
60 Oleanolic acid C30H48O3 456.360 3 508-02-1
61 Ursolic acid C30H48O3 456.360 3 77-52-1
62 Pyruvic acid C3H4O3 88.016 0 127-17-3
63 Malonic acid C3H4O4 104.011 0 141-82-2
64 Propionic acid C3H6O2 74.036 8 29102
65 Lactic acid C3H6O3 90.031 7 50-21-5
66 Maleic acid C4H4O4 116.011 0 110-16-7
67 Fumaric acid C4H4O4 116.011 0 110-17-8
68 Succinic acid C4H6O4 118.026 6 110-15-6
69 Malic acid C4H6O5 134.021 5 6915-15-7
70 Tartaric acid C4H6O6 150.016 4 526-83-0
71 Butyric acid C4H8O2 88.052 4 107-92-6
72 4-Aminobutyric acid C4H9NO2 103.063 3 20791
73 D-Glucuronic acid C6H10O7 194.042 7 1700908
74 Nicotinic acid C6H5NO2 123.032 0 59-67-6
75 Sorbic acid C6H8O2 112.052 4 110-44-1
76 Citric acid C6H8O7 192.027 0 77-92-9
77 Shikimic acid C7H10O5 174.052 8 138-59-0
78 Quinic acid C7H12O6 192.063 4 77-95-2
79 Benzoic acid C7H6O2 122.036 8 65-85-0
80 4-Hydroxybenzoic acid C7H6O3 138.031 7 99-96-7
81 Salicylic acid C7H6O3 138.031 7 69-72-7
82 2, 4-Dihydroxybenzoic acid C7H6O4 154.026 6 89-86-1
83 Protocatechuic acid C7H6O4 154.026 6 99-50-3
84 Gallic acid C7H6O5 170.021 5 149-91-7
85 2-Methoxybenzoic acid C8H8O3 152.047 3 529-75-9
86 Vanillic acid C8H8O4 168.042 3 121-34-6
87 3-(4-Hydroxyphenyl)propionic acid C9H10O3 166.063 0 501-97-3
88 Syringic acid C9H10O5 198.052 8 530-57-4
89 Cinnamic acid C9H8O2 148.052 4 621-82-9
90 trans-Cinnamic acid C9H8O2 148.052 4 140-10-3
91 Caffeic acid C9H8O4 180.042 3 331-39-5
92 Formic acid CH2O2 46.005 5 64-18-6
93 Sulfamic acid H3NO3S 96.983 4 5329-14-6
94 Sucrose C12H24O12 360.310 0 5989-81-1
95 Fructose C6H12O6 180.160 0 7660-25-5
96 Glucose C6H12O6 180.160 0 50-99-7
97 Xylose C5H10O5 150.130 0 58-86-6
98 Maltose C12H22O11 342.300 0 69-79-4
99 Monacolin O C25H40O8 468.580 0 -
100 Monacolin N C19H28O3 304.420 0 -
101 Monasscusic acid A C15H22O2 234.161 9 -
), ArticleFig(id=1198960245688074812, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, label=Table 1, caption=

Chemical consituents database of Xuezhikang Capsula base on UNIFI software

, figureFileSmall=null, figureFileBig=null, tableContent=
No. Compound name Formula Mr/Da CAS No.
1 4-Methoxycinnamic acid C10H10O3 178.063 0 830-09-1
2 3-Hydroxy-4-methoxycinnamic acid C10H10O4 194.057 9 537-73-5
3 Ferulic acid C10H10O4 194.057 9 1135-24-6
4 Ethylenediaminetetraacetic acid C10H16N2O8 292.090 7 60-00-4
5 Lunatinin C13H14O5 250.084 1 69364-81-4
6 Daidzein C15H10O4 254.057 9 486-66-8
7 Genistein C15H10O5 270.052 8 446-72-0
8 Cianidanol C15H14O6 290.079 0 154-23-4
9 Osthole C15H16O3 244.109 9 484-12-8
10 Glycitein C16H12O5 284.068 5 40957-83-3
11 Chlorogenic acid C16H18O9 354.095 1 327-97-9
12 ML-236C C18H26O3 290.188 2 58889-18-2
13 ML-236A C18H26O4 306.183 1 58889-19-3
14 Linoleic acid C18H32O2 280.240 2 60-33-3
15 Folic acid C19H19N7O6 441.139 7 59-30-3
16 Monacolin Q C19H22O2 282.162 0 1879038-89-7
17 α, β-Hydromonacolin Q C19H24O3 300.172 5 118045-32-2
18 Dehydromonacolin L C19H26O2 286.193 3 1355394-52-3
19 Dehydromonacolin J C19H26O3 302.188 2 1355394-51-2
20 Dehydromonacolin MV2 C19H26O5 334.178 0 -
21 α, β-Dehydrodihydromonacolin L C19H28O2 288.208 9 531523-94-1
22 Monacolin R C19H28O3 304.203 8 1879038-90-0
23 Monacolin L C19H28O3 304.203 8 79394-47-1
24 Monacolin J C19H28O4 320.198 8 79952-42-4
25 Dihydromonacolin L C19H30O3 306.219 5 86827-77-2
26 3α-Hydroxy-3, 5-dihydromonacolin L C19H30O4 322.214 4 119786-66-2
27 Sterculic acid C19H34O2 294.255 9 738-87-4
28 Monacolin L acid methyl ester C20H32O4 336.230 1 312710-94-4
29 Monalbidin N5 C20H32O5 352.225 0 2769120-20-7
30 Rubropunctatine C21H22O5 354.146 7 514-67-0
31 Rubropunctamine C21H23NO4 353.162 7 514-66-9
32 Monascin C21H26O5 358.178 0 21516-68-7
33 Dehydromonacolin N C21H28O4 344.198 8 1355394-50-1
34 6-α-O-Ethyl-4, 6-dihydromonacoline L C21H34O4 350.245 7 -
35 Monacolin T C21H36O5 368.256 3 -
36 Monacolin N1 C22H34O6 394.235 5 -
37 Monacolin U C22H38O5 382.271 9 -
38 Rotiorinol A C23H26O5 382.178 0 901309-41-9
39 Monascorubrin C23H26O5 382.178 0 13283-90-4
40 Monascorubramin C23H27NO4 381.194 0 3627-51-8
41 Robustadial A C23H30O5 386.209 3 88130-99-8
42 Mevastatin C23H34O5 390.240 6 73573-88-3
43 Monacolin M C23H34O6 406.235 5 106909-04-0
44 Dehydromonacolin K C24H34O4 386.245 7 109273-98-5
45 Monacolin X C24H34O6 418.235 5 96497-73-3
46 α, β-Dehydrodihydromonacolin K C24H36O4 388.261 4 312710-92-2
47 Monacolin K C24H36O5 404.256 3 75330-75-5
48 Dihydromonacolin K C24H38O5 406.271 9 77517-29-4
49 Dehydromonacolin MV C24H38O5 406.271 9 935846-59-6
50 Lovastatin acid C24H38O6 422.266 8 77550-67-5
51 Monacolin S C24H38O7 438.261 8 -
52 Monacolin K methyl ester C25H40O6 436.282 5 77934-80-6
53 Monacolin K ethyl ester C26H42O6 450.298 1 77517-31-8
54 Ergosterol C28H44O 396.339 2 57-87-4
55 Stigmasterin C29H48O 412.370 5 83-48-7
56 Oxalic acid C2H2O4 89.995 3 144-62-7
57 Acetic acid C2H4O2 60.021 1 64-19-7
58 Glycolic acid C2H4O3 76.016 0 79-14-1
59 β-Glycyrrhetinic acid C30H46O4 470.339 6 471-53-4
60 Oleanolic acid C30H48O3 456.360 3 508-02-1
61 Ursolic acid C30H48O3 456.360 3 77-52-1
62 Pyruvic acid C3H4O3 88.016 0 127-17-3
63 Malonic acid C3H4O4 104.011 0 141-82-2
64 Propionic acid C3H6O2 74.036 8 29102
65 Lactic acid C3H6O3 90.031 7 50-21-5
66 Maleic acid C4H4O4 116.011 0 110-16-7
67 Fumaric acid C4H4O4 116.011 0 110-17-8
68 Succinic acid C4H6O4 118.026 6 110-15-6
69 Malic acid C4H6O5 134.021 5 6915-15-7
70 Tartaric acid C4H6O6 150.016 4 526-83-0
71 Butyric acid C4H8O2 88.052 4 107-92-6
72 4-Aminobutyric acid C4H9NO2 103.063 3 20791
73 D-Glucuronic acid C6H10O7 194.042 7 1700908
74 Nicotinic acid C6H5NO2 123.032 0 59-67-6
75 Sorbic acid C6H8O2 112.052 4 110-44-1
76 Citric acid C6H8O7 192.027 0 77-92-9
77 Shikimic acid C7H10O5 174.052 8 138-59-0
78 Quinic acid C7H12O6 192.063 4 77-95-2
79 Benzoic acid C7H6O2 122.036 8 65-85-0
80 4-Hydroxybenzoic acid C7H6O3 138.031 7 99-96-7
81 Salicylic acid C7H6O3 138.031 7 69-72-7
82 2, 4-Dihydroxybenzoic acid C7H6O4 154.026 6 89-86-1
83 Protocatechuic acid C7H6O4 154.026 6 99-50-3
84 Gallic acid C7H6O5 170.021 5 149-91-7
85 2-Methoxybenzoic acid C8H8O3 152.047 3 529-75-9
86 Vanillic acid C8H8O4 168.042 3 121-34-6
87 3-(4-Hydroxyphenyl)propionic acid C9H10O3 166.063 0 501-97-3
88 Syringic acid C9H10O5 198.052 8 530-57-4
89 Cinnamic acid C9H8O2 148.052 4 621-82-9
90 trans-Cinnamic acid C9H8O2 148.052 4 140-10-3
91 Caffeic acid C9H8O4 180.042 3 331-39-5
92 Formic acid CH2O2 46.005 5 64-18-6
93 Sulfamic acid H3NO3S 96.983 4 5329-14-6
94 Sucrose C12H24O12 360.310 0 5989-81-1
95 Fructose C6H12O6 180.160 0 7660-25-5
96 Glucose C6H12O6 180.160 0 50-99-7
97 Xylose C5H10O5 150.130 0 58-86-6
98 Maltose C12H22O11 342.300 0 69-79-4
99 Monacolin O C25H40O8 468.580 0 -
100 Monacolin N C19H28O3 304.420 0 -
101 Monasscusic acid A C15H22O2 234.161 9 -
), ArticleFig(id=1198960245818098251, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=EN, label=null, caption=null, figureFileSmall=null, figureFileBig=null, tableContent=
Peak No. Compound name tR /min Formula Diff /×10-6 Molecular ion m/z Fragment ion MS2 Peak area
Lot. No.H20211210 Lot. No. 20211020 Lot. No. 20211040 Lot. No. 20211256
1 D-Glucuronic acid 2.63 C6H10O7 -5.8 193.048 4 157.036 5, 134.046 9, 123.055 9, 114.020 7, 113.025 0, 110.034 3, 89.029 1 876 14 289 14 823 13 659
2 Maltose 2.65 C12H22O11 -1.9 365.093 0 325.124 8, 296.077 0, 258.123 7, 184.080 2, 104.122 8, 86.111 6 102 373 1 364 014 1 190 990 1 383 216
3 Tartaric acid 2.65 C4H6O6 -2.6 149.021 9 134.047 0, 96.968 8, 78.958 6, 85.029 1, 72.992 6, 67.015 9 9 535 20 282 20 178 18 919
4 4-Aminobutyric acid 2.69 C4H9NO2 -4.2 102.055 6 71.013 3, 88.039 9, 74.024 4, 70.029 2, 59.013 2 - 14 237 14 464 11 983
5 Lactic acid 2.77 C3H6O3 -7.4 89.023 8 55.018 3, 59.013 2, 71.013 3, 73.029 0 - 103 584 103 842 101 214
6 Xylose 2.81 C5H10O5 -2.1 149.045 2 132.030 3, 119.034 8, 113.025 0, 101.024 2, 89.024 0, 83.013 1, 75.008 3, 71.013 2 - 26 364 28 224 27 332
7 Fructose 2.86 C6H12O6 -1.2 179.055 9 132.030 3, 119.034 8, 113.025 0, 101.024 2, 89.024 0, 83.013 1, 75.008 3, 71.013 3 - 303 427 269 437 278 251
8 Glycolic acid 2.87 C2H4O3 -9.5 75.008 1 59.013 2 - 17 441 16 973 15 684
9 5-O-Acetyl-α-L-arabinofuranose 2.95 C7H12O6 -1.7 191.055 8 157.036 5, 134.047 0, 113.025 0, 123.055 9, 85.029 1, 75.008 3, 69.034 0, 57.033 9 - 79 455 97 701 81 799
10 Malic acid DL 3.28 C4H6O5 -1.6 133.014 0 115.003 5, 102.055 6, 88.039 9, 70.029 3 - 346 299 342 945 332 019
11 Fumaric acid 3.28 C4H4O4 -2.6 115.003 4 82.029 4 - 163 580 162 341 156 966
12 Malonic acid 3.78 C3H4O4 -3.8 103.003 3 88.040 0, 71.013 2, 59.013 2 - 3 624 3 747 3 565
13 Citric acid 4.14 C6H8O7 -0.3 191.019 7 173.007 7, 111.008 3, 96.957 3, 87.006 1 - 417 662 400 554 381 029
14 Succinic acid 4.56 C4H6O4 -4.9 117.018 8 73.029 0 - 8 229 9 050 8 548
15 Maleic acid 4.7 C4H4O4 -2.7 115.003 4 98.007 1, 71.013 3 - 16 245 17 853 16 797
16 trans-Cinnamic acid 5.68 C9H8O2 -7.9 147.044 0 71.013 4 - 6 002 3 256 3 443
17 Shikimic acid 6.11 C7H10O5 0.2 173.058 9 127.050 9, 96.961 6, 111.019 5, 113.029 1, 78.958 7, 78.958 7, 87.008 4, 71.013 4 661 8 158 8 267 7 705
18 Salicylic acid 11.76 C7H6O3 -2.8 137.024 0 122.061 0 - 7 245 8 321 8 538
19 Vanillic acid 11.79 C8H8O4 -0.5 169.056 5 123.045 2, 137.063 8, 102.949 2 20 219 23 920 20 665
20 3-(4-Hydroxyphenyl) propionic acid 12.24 C9H10O3 -1.6 165.055 5 129.066 1, 73.028 2 - 52 745 52 355 46 612
21 Quinic acid 12.25 C7H12O6 -27.4 193.065 4 70.080 0, 129.118 6, 145.066 0 - 25 389 26 591 23 342
22 Syringic acid 13 C9H10O5 -2.8 197.045 0 153.060 9, 163.077 5, 130.050 3, 121.028 9 - 44 036 37 359 34 663
23 Pulchellalactam 13.75 C9H13NO -1.7 174.092 0 110.039 9, 84.060 9 10 090 95 996 84 544 79 336
24 Protocatechuic acid 14.08 C7H6O4 -0.6 153.019 2 135.961 1, 109.029 1, 91.018 4 - 652 767 584 749 510 170
25 Gallic acid 14.11 C7H6O5 -1.2 169.014 0 153.019 7, 109.029 1 - 64 772 61 014 52 139
26 Benzoic acid 14.22 C7H6O2 -2.4 121.029 2 162.019 8, 164.072 5, 145.062 2, 94.029 8, 59.013 4 - 10 418 8 838 8 154
27 Caffeic acid 14.99 C9H8O4 -1.8 179.048 2 974 9 173 11 599 10 338
28 Ferulic acid 16.12 C10H10O4 -1.2 193.050 4 161.060 2, 131.042 2, 89.024 1 - 45 429 40 217 36 787
29 3-Hydroxy-4-methoxycinnamic acid 18.26 C10H10O4 -2.8 193.050 1 145.029 2, 122.063 3 - 9 994 10 030 9 656
30 Catechin 18.46 C15H14O6 -1.5 289.071 3 147.081 4, 137.061 1 - 24 113 38 921 30 167
31 2, 4-Dihydroxybenzoic acid 19.44 C7H6O4 -0.2 153.019 3 107.049 9 - 36 817 31 217 29 701
32 Monacolin Q 19.9 C19H22O2 5.9 283.152 4 259.151 4, 215.123 3, 171.096 1, 143.064 3, 105.049 4, 93.049 3 104 933 - - -
33 Daidzein 20.06 C15H10O4 0.1 253.030 0 132.021 9, 91.018 8, 77.039 3, 135.008 8, 131.049 6 485 135 3 899 368 3 637 921 3 410 499
34 4-Hydroxybenzoic acid 20.08 C7H6O3 -1.8 137.024 2 103.055 1, 93.034 3 - 35 229 25 782 25 822
35 4-Methoxycinnamic acid 20.12 C10H10O3 -3.5 177.055 1 162.021 8, 159.044 6, 131.049 4, 107.049 8 - 4 600 4 371 4 419
36 Glycitein 20.38 C16H12O5 -0.7 283.061 2 268.037 8, 265.071 7, 175.039 5, 162.021 8, 149.060 7, 137.024 3, 93.034 3 614 625 356 303 328 875 285 907
37 α, β-Hydromonacolin Q 20.56 C19H24O3 -4.8 301.163 4 241.139 9, 215.123 1, 165.049 3, 143.064 3, 105.049 4, 81.049 9 507 276 13 591 11 730 10 033
38 2-Methoxybenzoic acid 21.77 C8H8O3 -1.4 151.039 9 101.060 5, 137.061 0 - 18 145 18 832 16 522
39 Lunatinin 22.5 C13H14O5 -0.3 249.056 0 205.050 1, 204.042 3, 137.060 7, 159.044 5, 177.128 2, 190.026 7 89 570 1 050 002 1 170 119 1 094 398
40 Genistein 23.27 C15H10O5 0 271.072 8 253.064 6, 243.079 4, 215.084 4, 153.035 7, 91.069 9 597 519 5 677 178 5 477 400 5 122 723
41 Monalbidin N5 23.97 C20H32O5 -8.9 351.214 7 211.122 7, 311.170 4, 139.112 7, 171.102 4, 183.138 9, 209.118 2, 229.144 2 29 915 268 816 233 721 210 265
42 Dehydromonacolin MV2 24.37 C19H26O5 -0.3 333.153 9 171.102 3, 173.059 6, 139.112 7, 121.029 5, 155.081 9, 111.045 0, 211.096 4 22 166 170 082 175 682 142 503
43 Monacolin J 24.99 C19H28O4 9.8 321.190 1 223 355 - - -
44 3α-Hydroxy-3, 5-dihydromonacolin L 25.61 C19H30O4 -9.5 345.189 7 283.119 8, 227.160 2, 185.112 2, 157.080 2, 143.064 2, 105.049 3, 91.034 3 152 093 31 338 30 256 27 547
45 Dehydromonacolin N 26.46 C21H28O4 -1.3 343.191 0 83.013 6, 296.104 5, 319.191 1, 326.139 8, 237.090 4, 213.090 3, 113.096 9 1 365 850 1 321 654 1 463 439 1 313 218
46 Monacolin T 27.5 C21H36O5 -0.7 367.220 4 352.155 6, 323.201 0, 295.097 3, 251.106 9, 227.201 3, 183.012 1, 112.985 5 132 055 - - -
47 Monacolin S 28.06 C24H38O7 -2.2 437.244 8 213.135 5, 195.125 5, 143.101 4, 128.078 5, 67.068 9 65 233 245 056 230 630 198 961
48 Rubropunctamine 28.69 C21H23NO4 0 352.155 4 337.131 2, 313.143 3, 294.077 5, 250.088 3, 239.060 0, 226.087 5, 199.073 1 137 026 137 203 203 083 186 753
49 Chlorogenic acid 30.3 C16H18O9 3.1 353.088 9 150.128 9, 107.050 0, 66.034 3, 311.169 2, 222.080 6, 198.0922, 163.0760 - 47 138 25 006 28 293
50 Monacolin N1 30.78 C22H34O6 -1.2 393.227 8 295.1720, 281.2481, 213.0903, 313.1796, 231.0653, 252.993 1, 197.058 9 - 39 731 37 186 32 854
51 Dehydromonacolin J 31.92 C19H26O3 -0.3 303.179 5 249.145 2, 225.144 4, 91.034 4, 143.064 5 258 407 115 817 110 511 92 830
52 Monacolin R 32.67 C19H28O3 -4.6 305.194 7 275.113 8, 257.102 6, 197.112 0 113 422 36 067 31 032 29 334
53 Monacolin X 32.79 C24H34O6 0.1 441.216 7 325.189 4, 243.188 6, 403.219 8, 315.116 7, 225.178 6, 223.162 9 577 296 4 013 873 3 995 584 3 589 582
54 Monacolin K methyl ester 33.16 C25H40O6 9.9 459.289 8 360.214 4, 261.141 9, 233.145 8 1 734 009 - - -
55 Monacolin M 33.41 C23H34O6 -1.2 429.215 4 382.190 7, 310.164 3, 195.096 3 37 702 71 415 75 500 63 236
56 Monascorubramin 33.47 C23H27NO4 -1.7 380.172 5 180.066 5, 113.096 9, 146.965 2, 215.107 0, 199.075 2, 231.065 9, 354.168 7 11 464 57 424 95 696 89 002
57 Monascorubrin 34.84 C23H26O5 18.2 383.171 1 271.219 0, 215.122 1, 69.048 3, 159.132 8, 187.127 5, 201.106 1 1 648 252 1 009 430 1 500 822 1 409 028
58 Lovastatin acid 35.38 C24H38O6 -0.5 421.264 0 319.187 0, 101.060 5, 85.0291 5 6 802 308 14 892 602 14 881 085 14 144 736
59 Monacolin L 36.54 C19H28O3 27.9 305.195 3 227.160 0, 145.080 2 227 410 268 411 217 457
60 Mevastatin 36.89 C23H34O5 19.6 413.220 3 337.185 1, 325.189 5, 220.052 5, 169.117 1, 143.101 6, 59.045 3 543 206 1 929 575 1 735 687 1 582 262
61 Monasscusic acid A 37.48 C15H22O2 -0.7 233.133 2 183.012 3, 130.087 1, 101.024 2, 89.024 3, 209.117 9, 172.098 0, 161.045 9, 119.035 2 58 068 417 441 401 220 362 604
62 Rubropunctatine 37.86 C21H22O5 4.3 355.174 5 287.183 6, 241.176 8, 217.102 7, 315.179 9 1 345 094 10 773 3 568 8 197
63 Monascin 38.33 C21H26O5 -1.5 359.172 1 215.122 8, 187.125 4, 184.085 6, 159.134 2 7 532 339 2 762 643 5 381 906 5 173 440
64 Sterculic acid 38.56 C19H34O2 2.5 293.249 3 279.232 9, 112.985 5, 83.013 0, 233.154 4 - 4 336 9 954 4 039
65 Dehydromonacolin MV 38.64 C24H38O5 0 407.283 9 352.325 8, 262.234 5, 293.196 0, 319.180 8 262 691 - - -
66 Monacolin K 38.98 C24H36O5 17.7 427.235 7 325.189 5, 275.145 6, 201.179 1, 81.085 1, 373.244 1, 309.189 7 10 949 357 2 569 933 2 367 384 2 153 723
67 ML-236A 39.34 C18H26O4 0 307.203 2 263.225 1, 163.127 0, 104.086 1, 189.143 4 79 969 - - -
68 ML-236C 39.87 C18H26O3 -6.6 313.175 3 239.251 6, 171.096 6, 95.101 5, 71.100 4 - 82 594 116 386 102 528
69 Monacolin U 40.22 C22H38O5 -6.2 405.263 4 343.198 3, 275.145 6, 239.251 4, 67.068 9, 313.285 9, 331.295 7, 303.210 0 10 721 10 063 11 225 11 940
70 Dihydromonacolin L 41.54 C19H30O3 -1.4 305.193 6 183.012 2, 253.253 8, 119.050 5, 96.960 3, 59.013 3, 171.103 2 15 005 232 651 272 294 256 969
71 Oleanolic acid 41.56 C30H48O3 -1.1 455.352 6 255.233 1, 421.259 5, 339.200 5, 101.060 6, 370.166 0, 150.988 9 - 5 379 4 266 5 520
72 Monacolin K ethyl ester 42.01 C26H42O6 11.3 473.264 7 184.089 5, 104.122 9, 86.111 9, 125.016 1, 225.178 4, 339.300 5 45 804 8 625 390 8 994 605 8 377 235
73 Dihydromonacolin K 42.9 C24H38O5 4.5 429.251 9 327.204 7, 227.194 2, 145.117 3, 105.085 8, 73.061 6, 388.347 7, 287.213 5, 269.203 5 5 339 528 11 652 522 10 612 139 12 123 037
74 Robustadial A 43.03 C23H30O5 -0.9 385.201 7 339.201 4, 303.103 1, 311.166 6, 209.118 1, 150.989 0, 119.050 0, 263.105 8, 299.258 3 905 113 240 302 478 813 494 002
75 Dehydromonacolin K 44 C24H34O4 0.1 409.224 4 307.175 5, 207.129 1, 155.100 6, 143.101 3 5 243 291 12 547 357 11 949 148 11 768 099
76 Stigmasterin 44.61 C29H48O 7.8 413.365 3 388.347 8, 276.282 2, 184.089 5, 146.998 5, 73.061 7 12 845 18 652 60 728 34 148
77 Linoleic acid 44.75 C18H32O2 0.5 279.213 9 237.149 5, 139.076 6, 84.938 7 2 703 347 11 519 718 11 277 397 10 979 486
78 Rotiorinol A 44.99 C23H26O5 9 381.174 2 281.248 5, 183.012 3, 171.006 5, 96.966 7, 139.076 5, 255.233 0, 325.183 9, 364.170 5 - 732 997 644 250 612 424
79 6-α-O-Ethyl-4, 6-dihydromonacoline L 45.11 C21H34O4 -6.4 349.236 2 183.012 3, 171.006 5, 152.995 9, 78.958 7, 96.966 7, 119.050 0, 151.076 4, 231.066 3 - 246 598 231 563 222 912
80 Ursolic acid 45.41 C30H48O3 0.2 455.353 2 281.248 5, 411.206 8, 352.155 5, 325.183 6, 253.091 4, 163.112 7 - 22 599 22 305 22 527
81 Ergosterol 46.8 C28H44O 3.8 419.330 1 352.350 8, 313.191 3, 247.162 3, 67.068 9, 173.148 4, 157.117 2 - 15 471 11 298 11 257
82 α, β-Dehydrodihydromonacolin K 50.87 C24H36O4 19.8 411.258 7 331.185 3, 287.213 8, 201.179 4, 145.117 4, 309.194 2, 241.209 7, 131.101 8 - 5 260 974 4 310 157 4 252 835
), ArticleFig(id=1198960246006841948, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, language=CN, label=Table 2, caption=

Qualitative identification results of chemical components of Xuezhikang Capsula base on UNIFI database

, figureFileSmall=null, figureFileBig=null, tableContent=
Peak No. Compound name tR /min Formula Diff /×10-6 Molecular ion m/z Fragment ion MS2 Peak area
Lot. No.H20211210 Lot. No. 20211020 Lot. No. 20211040 Lot. No. 20211256
1 D-Glucuronic acid 2.63 C6H10O7 -5.8 193.048 4 157.036 5, 134.046 9, 123.055 9, 114.020 7, 113.025 0, 110.034 3, 89.029 1 876 14 289 14 823 13 659
2 Maltose 2.65 C12H22O11 -1.9 365.093 0 325.124 8, 296.077 0, 258.123 7, 184.080 2, 104.122 8, 86.111 6 102 373 1 364 014 1 190 990 1 383 216
3 Tartaric acid 2.65 C4H6O6 -2.6 149.021 9 134.047 0, 96.968 8, 78.958 6, 85.029 1, 72.992 6, 67.015 9 9 535 20 282 20 178 18 919
4 4-Aminobutyric acid 2.69 C4H9NO2 -4.2 102.055 6 71.013 3, 88.039 9, 74.024 4, 70.029 2, 59.013 2 - 14 237 14 464 11 983
5 Lactic acid 2.77 C3H6O3 -7.4 89.023 8 55.018 3, 59.013 2, 71.013 3, 73.029 0 - 103 584 103 842 101 214
6 Xylose 2.81 C5H10O5 -2.1 149.045 2 132.030 3, 119.034 8, 113.025 0, 101.024 2, 89.024 0, 83.013 1, 75.008 3, 71.013 2 - 26 364 28 224 27 332
7 Fructose 2.86 C6H12O6 -1.2 179.055 9 132.030 3, 119.034 8, 113.025 0, 101.024 2, 89.024 0, 83.013 1, 75.008 3, 71.013 3 - 303 427 269 437 278 251
8 Glycolic acid 2.87 C2H4O3 -9.5 75.008 1 59.013 2 - 17 441 16 973 15 684
9 5-O-Acetyl-α-L-arabinofuranose 2.95 C7H12O6 -1.7 191.055 8 157.036 5, 134.047 0, 113.025 0, 123.055 9, 85.029 1, 75.008 3, 69.034 0, 57.033 9 - 79 455 97 701 81 799
10 Malic acid DL 3.28 C4H6O5 -1.6 133.014 0 115.003 5, 102.055 6, 88.039 9, 70.029 3 - 346 299 342 945 332 019
11 Fumaric acid 3.28 C4H4O4 -2.6 115.003 4 82.029 4 - 163 580 162 341 156 966
12 Malonic acid 3.78 C3H4O4 -3.8 103.003 3 88.040 0, 71.013 2, 59.013 2 - 3 624 3 747 3 565
13 Citric acid 4.14 C6H8O7 -0.3 191.019 7 173.007 7, 111.008 3, 96.957 3, 87.006 1 - 417 662 400 554 381 029
14 Succinic acid 4.56 C4H6O4 -4.9 117.018 8 73.029 0 - 8 229 9 050 8 548
15 Maleic acid 4.7 C4H4O4 -2.7 115.003 4 98.007 1, 71.013 3 - 16 245 17 853 16 797
16 trans-Cinnamic acid 5.68 C9H8O2 -7.9 147.044 0 71.013 4 - 6 002 3 256 3 443
17 Shikimic acid 6.11 C7H10O5 0.2 173.058 9 127.050 9, 96.961 6, 111.019 5, 113.029 1, 78.958 7, 78.958 7, 87.008 4, 71.013 4 661 8 158 8 267 7 705
18 Salicylic acid 11.76 C7H6O3 -2.8 137.024 0 122.061 0 - 7 245 8 321 8 538
19 Vanillic acid 11.79 C8H8O4 -0.5 169.056 5 123.045 2, 137.063 8, 102.949 2 20 219 23 920 20 665
20 3-(4-Hydroxyphenyl) propionic acid 12.24 C9H10O3 -1.6 165.055 5 129.066 1, 73.028 2 - 52 745 52 355 46 612
21 Quinic acid 12.25 C7H12O6 -27.4 193.065 4 70.080 0, 129.118 6, 145.066 0 - 25 389 26 591 23 342
22 Syringic acid 13 C9H10O5 -2.8 197.045 0 153.060 9, 163.077 5, 130.050 3, 121.028 9 - 44 036 37 359 34 663
23 Pulchellalactam 13.75 C9H13NO -1.7 174.092 0 110.039 9, 84.060 9 10 090 95 996 84 544 79 336
24 Protocatechuic acid 14.08 C7H6O4 -0.6 153.019 2 135.961 1, 109.029 1, 91.018 4 - 652 767 584 749 510 170
25 Gallic acid 14.11 C7H6O5 -1.2 169.014 0 153.019 7, 109.029 1 - 64 772 61 014 52 139
26 Benzoic acid 14.22 C7H6O2 -2.4 121.029 2 162.019 8, 164.072 5, 145.062 2, 94.029 8, 59.013 4 - 10 418 8 838 8 154
27 Caffeic acid 14.99 C9H8O4 -1.8 179.048 2 974 9 173 11 599 10 338
28 Ferulic acid 16.12 C10H10O4 -1.2 193.050 4 161.060 2, 131.042 2, 89.024 1 - 45 429 40 217 36 787
29 3-Hydroxy-4-methoxycinnamic acid 18.26 C10H10O4 -2.8 193.050 1 145.029 2, 122.063 3 - 9 994 10 030 9 656
30 Catechin 18.46 C15H14O6 -1.5 289.071 3 147.081 4, 137.061 1 - 24 113 38 921 30 167
31 2, 4-Dihydroxybenzoic acid 19.44 C7H6O4 -0.2 153.019 3 107.049 9 - 36 817 31 217 29 701
32 Monacolin Q 19.9 C19H22O2 5.9 283.152 4 259.151 4, 215.123 3, 171.096 1, 143.064 3, 105.049 4, 93.049 3 104 933 - - -
33 Daidzein 20.06 C15H10O4 0.1 253.030 0 132.021 9, 91.018 8, 77.039 3, 135.008 8, 131.049 6 485 135 3 899 368 3 637 921 3 410 499
34 4-Hydroxybenzoic acid 20.08 C7H6O3 -1.8 137.024 2 103.055 1, 93.034 3 - 35 229 25 782 25 822
35 4-Methoxycinnamic acid 20.12 C10H10O3 -3.5 177.055 1 162.021 8, 159.044 6, 131.049 4, 107.049 8 - 4 600 4 371 4 419
36 Glycitein 20.38 C16H12O5 -0.7 283.061 2 268.037 8, 265.071 7, 175.039 5, 162.021 8, 149.060 7, 137.024 3, 93.034 3 614 625 356 303 328 875 285 907
37 α, β-Hydromonacolin Q 20.56 C19H24O3 -4.8 301.163 4 241.139 9, 215.123 1, 165.049 3, 143.064 3, 105.049 4, 81.049 9 507 276 13 591 11 730 10 033
38 2-Methoxybenzoic acid 21.77 C8H8O3 -1.4 151.039 9 101.060 5, 137.061 0 - 18 145 18 832 16 522
39 Lunatinin 22.5 C13H14O5 -0.3 249.056 0 205.050 1, 204.042 3, 137.060 7, 159.044 5, 177.128 2, 190.026 7 89 570 1 050 002 1 170 119 1 094 398
40 Genistein 23.27 C15H10O5 0 271.072 8 253.064 6, 243.079 4, 215.084 4, 153.035 7, 91.069 9 597 519 5 677 178 5 477 400 5 122 723
41 Monalbidin N5 23.97 C20H32O5 -8.9 351.214 7 211.122 7, 311.170 4, 139.112 7, 171.102 4, 183.138 9, 209.118 2, 229.144 2 29 915 268 816 233 721 210 265
42 Dehydromonacolin MV2 24.37 C19H26O5 -0.3 333.153 9 171.102 3, 173.059 6, 139.112 7, 121.029 5, 155.081 9, 111.045 0, 211.096 4 22 166 170 082 175 682 142 503
43 Monacolin J 24.99 C19H28O4 9.8 321.190 1 223 355 - - -
44 3α-Hydroxy-3, 5-dihydromonacolin L 25.61 C19H30O4 -9.5 345.189 7 283.119 8, 227.160 2, 185.112 2, 157.080 2, 143.064 2, 105.049 3, 91.034 3 152 093 31 338 30 256 27 547
45 Dehydromonacolin N 26.46 C21H28O4 -1.3 343.191 0 83.013 6, 296.104 5, 319.191 1, 326.139 8, 237.090 4, 213.090 3, 113.096 9 1 365 850 1 321 654 1 463 439 1 313 218
46 Monacolin T 27.5 C21H36O5 -0.7 367.220 4 352.155 6, 323.201 0, 295.097 3, 251.106 9, 227.201 3, 183.012 1, 112.985 5 132 055 - - -
47 Monacolin S 28.06 C24H38O7 -2.2 437.244 8 213.135 5, 195.125 5, 143.101 4, 128.078 5, 67.068 9 65 233 245 056 230 630 198 961
48 Rubropunctamine 28.69 C21H23NO4 0 352.155 4 337.131 2, 313.143 3, 294.077 5, 250.088 3, 239.060 0, 226.087 5, 199.073 1 137 026 137 203 203 083 186 753
49 Chlorogenic acid 30.3 C16H18O9 3.1 353.088 9 150.128 9, 107.050 0, 66.034 3, 311.169 2, 222.080 6, 198.0922, 163.0760 - 47 138 25 006 28 293
50 Monacolin N1 30.78 C22H34O6 -1.2 393.227 8 295.1720, 281.2481, 213.0903, 313.1796, 231.0653, 252.993 1, 197.058 9 - 39 731 37 186 32 854
51 Dehydromonacolin J 31.92 C19H26O3 -0.3 303.179 5 249.145 2, 225.144 4, 91.034 4, 143.064 5 258 407 115 817 110 511 92 830
52 Monacolin R 32.67 C19H28O3 -4.6 305.194 7 275.113 8, 257.102 6, 197.112 0 113 422 36 067 31 032 29 334
53 Monacolin X 32.79 C24H34O6 0.1 441.216 7 325.189 4, 243.188 6, 403.219 8, 315.116 7, 225.178 6, 223.162 9 577 296 4 013 873 3 995 584 3 589 582
54 Monacolin K methyl ester 33.16 C25H40O6 9.9 459.289 8 360.214 4, 261.141 9, 233.145 8 1 734 009 - - -
55 Monacolin M 33.41 C23H34O6 -1.2 429.215 4 382.190 7, 310.164 3, 195.096 3 37 702 71 415 75 500 63 236
56 Monascorubramin 33.47 C23H27NO4 -1.7 380.172 5 180.066 5, 113.096 9, 146.965 2, 215.107 0, 199.075 2, 231.065 9, 354.168 7 11 464 57 424 95 696 89 002
57 Monascorubrin 34.84 C23H26O5 18.2 383.171 1 271.219 0, 215.122 1, 69.048 3, 159.132 8, 187.127 5, 201.106 1 1 648 252 1 009 430 1 500 822 1 409 028
58 Lovastatin acid 35.38 C24H38O6 -0.5 421.264 0 319.187 0, 101.060 5, 85.0291 5 6 802 308 14 892 602 14 881 085 14 144 736
59 Monacolin L 36.54 C19H28O3 27.9 305.195 3 227.160 0, 145.080 2 227 410 268 411 217 457
60 Mevastatin 36.89 C23H34O5 19.6 413.220 3 337.185 1, 325.189 5, 220.052 5, 169.117 1, 143.101 6, 59.045 3 543 206 1 929 575 1 735 687 1 582 262
61 Monasscusic acid A 37.48 C15H22O2 -0.7 233.133 2 183.012 3, 130.087 1, 101.024 2, 89.024 3, 209.117 9, 172.098 0, 161.045 9, 119.035 2 58 068 417 441 401 220 362 604
62 Rubropunctatine 37.86 C21H22O5 4.3 355.174 5 287.183 6, 241.176 8, 217.102 7, 315.179 9 1 345 094 10 773 3 568 8 197
63 Monascin 38.33 C21H26O5 -1.5 359.172 1 215.122 8, 187.125 4, 184.085 6, 159.134 2 7 532 339 2 762 643 5 381 906 5 173 440
64 Sterculic acid 38.56 C19H34O2 2.5 293.249 3 279.232 9, 112.985 5, 83.013 0, 233.154 4 - 4 336 9 954 4 039
65 Dehydromonacolin MV 38.64 C24H38O5 0 407.283 9 352.325 8, 262.234 5, 293.196 0, 319.180 8 262 691 - - -
66 Monacolin K 38.98 C24H36O5 17.7 427.235 7 325.189 5, 275.145 6, 201.179 1, 81.085 1, 373.244 1, 309.189 7 10 949 357 2 569 933 2 367 384 2 153 723
67 ML-236A 39.34 C18H26O4 0 307.203 2 263.225 1, 163.127 0, 104.086 1, 189.143 4 79 969 - - -
68 ML-236C 39.87 C18H26O3 -6.6 313.175 3 239.251 6, 171.096 6, 95.101 5, 71.100 4 - 82 594 116 386 102 528
69 Monacolin U 40.22 C22H38O5 -6.2 405.263 4 343.198 3, 275.145 6, 239.251 4, 67.068 9, 313.285 9, 331.295 7, 303.210 0 10 721 10 063 11 225 11 940
70 Dihydromonacolin L 41.54 C19H30O3 -1.4 305.193 6 183.012 2, 253.253 8, 119.050 5, 96.960 3, 59.013 3, 171.103 2 15 005 232 651 272 294 256 969
71 Oleanolic acid 41.56 C30H48O3 -1.1 455.352 6 255.233 1, 421.259 5, 339.200 5, 101.060 6, 370.166 0, 150.988 9 - 5 379 4 266 5 520
72 Monacolin K ethyl ester 42.01 C26H42O6 11.3 473.264 7 184.089 5, 104.122 9, 86.111 9, 125.016 1, 225.178 4, 339.300 5 45 804 8 625 390 8 994 605 8 377 235
73 Dihydromonacolin K 42.9 C24H38O5 4.5 429.251 9 327.204 7, 227.194 2, 145.117 3, 105.085 8, 73.061 6, 388.347 7, 287.213 5, 269.203 5 5 339 528 11 652 522 10 612 139 12 123 037
74 Robustadial A 43.03 C23H30O5 -0.9 385.201 7 339.201 4, 303.103 1, 311.166 6, 209.118 1, 150.989 0, 119.050 0, 263.105 8, 299.258 3 905 113 240 302 478 813 494 002
75 Dehydromonacolin K 44 C24H34O4 0.1 409.224 4 307.175 5, 207.129 1, 155.100 6, 143.101 3 5 243 291 12 547 357 11 949 148 11 768 099
76 Stigmasterin 44.61 C29H48O 7.8 413.365 3 388.347 8, 276.282 2, 184.089 5, 146.998 5, 73.061 7 12 845 18 652 60 728 34 148
77 Linoleic acid 44.75 C18H32O2 0.5 279.213 9 237.149 5, 139.076 6, 84.938 7 2 703 347 11 519 718 11 277 397 10 979 486
78 Rotiorinol A 44.99 C23H26O5 9 381.174 2 281.248 5, 183.012 3, 171.006 5, 96.966 7, 139.076 5, 255.233 0, 325.183 9, 364.170 5 - 732 997 644 250 612 424
79 6-α-O-Ethyl-4, 6-dihydromonacoline L 45.11 C21H34O4 -6.4 349.236 2 183.012 3, 171.006 5, 152.995 9, 78.958 7, 96.966 7, 119.050 0, 151.076 4, 231.066 3 - 246 598 231 563 222 912
80 Ursolic acid 45.41 C30H48O3 0.2 455.353 2 281.248 5, 411.206 8, 352.155 5, 325.183 6, 253.091 4, 163.112 7 - 22 599 22 305 22 527
81 Ergosterol 46.8 C28H44O 3.8 419.330 1 352.350 8, 313.191 3, 247.162 3, 67.068 9, 173.148 4, 157.117 2 - 15 471 11 298 11 257
82 α, β-Dehydrodihydromonacolin K 50.87 C24H36O4 19.8 411.258 7 331.185 3, 287.213 8, 201.179 4, 145.117 4, 309.194 2, 241.209 7, 131.101 8 - 5 260 974 4 310 157 4 252 835
)], attaches=null, journal=Journal(id=1189982048455397383, delFlag=0, nameCn=药学学报, nameEn=Acta Pharmaceutica Sinica, nameHistory1=null, nameHistory2=null, issn=0513-4870, eissn=null, cn=11-2163/R, coden=null, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=BTxjudbJDVO4PqdBR6On6Q==, journalPrice=null, startedYear=null, abbrevIsoEn=null, journalRemark=null, publicationField=null, createdTime=1761643429151, updatedTime=1788948913902, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Y, firstLetterEn=Y, subjectCode=Medical and Pharmaceutical Sciences, subjectName=Life Sciences, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=BTxjudbJDVO4PqdBR6On6Q==, picEn=c4l1ckL55nWbhl1KrFdWIA==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509553505227679, language=CN, name=药学学报, nameHistory1=null, nameHistory2=null, managedBy=中国科学技术协会, sponsoredBy=中国药学会、中国医学科学院药物研究所, publishedBy=《药学学报》编辑委员会编辑出版, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948914171, updatedTime=1788948914171, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.yxxb.com.cn/journalx_yxxb/authorLogOn.action, submissionEditorUrl=https://www.yxxb.com.cn/journalx_yxxb/editorLogOn.action, submissionReviewUrl=https://www.yxxb.com.cn/journalx_yxxb/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304509553559753632, language=EN, name=Acta Pharmaceutica Sinica, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948914184, updatedTime=1788948914184, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.yxxb.com.cn/journalx_yxxb/authorLogOn.action, submissionEditorUrl=https://www.yxxb.com.cn/journalx_yxxb/editorLogOn.action, submissionReviewUrl=https://www.yxxb.com.cn/journalx_yxxb/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1189982191388893191, websiteList=[Website(id=1189982271588340489, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1189982191388893191, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/yxxb/CN, language=CN, createTime=1761643482348, createBy=18614031015, updateTime=1761643498101, updateBy=18614031015, name=药学学报-中文, tplId=1146099689490845704, title=药学学报, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1189982873114448678, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271588340489, code=articleTextType, value=kx, createTime=1761643625763, updateTime=1761643625763, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982873093477155, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271588340489, code=banner, value=null, createTime=1761643625758, updateTime=1761643625758, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982873135420201, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271588340489, code=grayFlag, value=0, createTime=1761643625768, updateTime=1761643625768, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982873085088546, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271588340489, code=logo, value=https://castjournals.cast.org.cn/joweb/yxxb/CN/file/pic?fileId=w+t2v8bJnX5lh3+hRRJcDA==, createTime=1761643625756, updateTime=1761643625756, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982873152197419, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271588340489, code=minRunFlag, value=0, createTime=1761643625772, updateTime=1761643625772, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982873110254373, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271588340489, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/yxxb/CN/file/pic, createTime=1761643625762, updateTime=1761643625762, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982873143808810, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271588340489, code=silenceFlag, value=0, createTime=1761643625770, updateTime=1761643625770, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982873101865764, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271588340489, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1761643625760, updateTime=1761643625760, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982873122837287, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271588340489, code=themeColor, value=null, createTime=1761643625765, updateTime=1761643625765, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982873127031592, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271588340489, code=themeStyle, value=null, createTime=1761643625766, updateTime=1761643625766, creator=18614031015, updator=18614031015)]), Website(id=1189982271655449355, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1189982191388893191, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/yxxb/EN, language=EN, createTime=1761643482364, createBy=18614031015, updateTime=1761643514085, updateBy=18614031015, name=药学学报-英文, tplId=1146101810881728533, title=Acta Pharmaceutica Sinica, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1189982903015633534, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271655449355, code=articleTextType, value=kx, createTime=1761643632892, updateTime=1761643632892, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982902990467707, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271655449355, code=banner, value=null, createTime=1761643632886, updateTime=1761643632886, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982903036605057, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271655449355, code=grayFlag, value=0, createTime=1761643632897, updateTime=1761643632897, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982902982079098, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271655449355, code=logo, value=https://castjournals.cast.org.cn/joweb/yxxb/EN/file/pic?fileId=w+t2v8bJnX5lh3+hRRJcDA==, createTime=1761643632884, updateTime=1761643632884, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982903053382275, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271655449355, code=minRunFlag, value=0, createTime=1761643632901, updateTime=1761643632901, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982903007244925, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271655449355, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/yxxb/EN/file/pic, createTime=1761643632890, updateTime=1761643632890, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982903044993666, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271655449355, code=silenceFlag, value=0, createTime=1761643632899, updateTime=1761643632899, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982902998856316, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271655449355, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1761643632888, updateTime=1761643632888, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982903019827839, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271655449355, code=themeColor, value=null, createTime=1761643632893, updateTime=1761643632893, creator=18614031015, updator=18614031015), WebsiteProps(id=1189982903028216448, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189982271655449355, code=themeStyle, value=null, createTime=1761643632895, updateTime=1761643632895, creator=18614031015, updator=18614031015)])], journalTitle=药学学报, weixinUrl=null, journalUrl=https://www.yxxb.com.cn/aps, iacademicId=null, status=1, seqNo=null, journalTitleEn=Acta Pharmaceutica Sinica, journalPhotoCn=BTxjudbJDVO4PqdBR6On6Q==, journalPhotoEn=c4l1ckL55nWbhl1KrFdWIA==, journalFirstLetter=Y, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/yxxb/CN/10.16438/j.0513-4870.2023-0008, detailUrlEn=https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2023-0008, pdfUrlCn=https://castjournals.cast.org.cn/joweb/yxxb/CN/PDF/10.16438/j.0513-4870.2023-0008, pdfUrlEn=https://castjournals.cast.org.cn/joweb/yxxb/EN/PDF/10.16438/j.0513-4870.2023-0008, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=1, orderTime=1697040000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
基于UPLC-Q-TOF/MSE的UNIFI质谱数据库建立及其在血脂康胶囊化学成分的快速分析中的应用
收藏切换
PDF下载
田国芳 1 , 薛岚 2 , 刘曦 2 , 裴欢 2 , 唐煜 1, *
药学学报 | 专题报道: 中药制造质量控制与智能制造 2023,58(10): 2862-2874
收起
收藏切换
药学学报 |专题报道: 中药制造质量控制与智能制造 2023 , 58 (10) : 2862 -2874
基于UPLC-Q-TOF/MSE的UNIFI质谱数据库建立及其在血脂康胶囊化学成分的快速分析中的应用
全屏
[Author(id=1198960239757329318, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1198960240000598970, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960239757329318, language=EN, stringName=Guo-fang TIAN, firstName=Guo-fang, middleName=null, lastName=TIAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1. Center of Pharmaceutical Technology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1198960240143205321, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960239757329318, language=CN, stringName=田国芳, firstName=国芳, middleName=null, lastName=田, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.清华大学药学院, 清华大学药学技术中心, 北京 100084, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1198960239337898869, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, xref=null, ext=[AuthorCompanyExt(id=1198960239346287480, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239337898869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. Center of Pharmaceutical Technology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China), AuthorCompanyExt(id=1198960239371453306, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239337898869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.清华大学药学院, 清华大学药学技术中心, 北京 100084)])]), Author(id=1198960240290005981, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1198960240445195250, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960240290005981, language=EN, stringName=Lan XUE, firstName=Lan, middleName=null, lastName=XUE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1198960240558440452, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960240290005981, language=CN, stringName=薛岚, firstName=岚, middleName=null, lastName=薛, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.北京北大维信生物科技有限公司, 北京 100083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1198960239556002700, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, xref=null, ext=[AuthorCompanyExt(id=1198960239572779919, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China), AuthorCompanyExt(id=1198960239585362833, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.北京北大维信生物科技有限公司, 北京 100083)])]), Author(id=1198960240650715153, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1198960240784932894, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960240650715153, language=EN, stringName=Xi LIU, firstName=Xi, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1198960240923344936, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960240650715153, language=CN, stringName=刘曦, firstName=曦, middleName=null, lastName=刘, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.北京北大维信生物科技有限公司, 北京 100083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1198960239556002700, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, xref=null, ext=[AuthorCompanyExt(id=1198960239572779919, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China), AuthorCompanyExt(id=1198960239585362833, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.北京北大维信生物科技有限公司, 北京 100083)])]), Author(id=1198960241091117114, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1198960241225334851, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960241091117114, language=EN, stringName=Huan PEI, firstName=Huan, middleName=null, lastName=PEI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1198960241309220942, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960241091117114, language=CN, stringName=裴欢, firstName=欢, middleName=null, lastName=裴, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.北京北大维信生物科技有限公司, 北京 100083, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1198960239556002700, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, xref=null, ext=[AuthorCompanyExt(id=1198960239572779919, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China), AuthorCompanyExt(id=1198960239585362833, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239556002700, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.北京北大维信生物科技有限公司, 北京 100083)])]), Author(id=1198960241414078555, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=tangyu@tsinghua.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1198960241535713386, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960241414078555, language=EN, stringName=Yu TANG, firstName=Yu, middleName=null, lastName=TANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1. Center of Pharmaceutical Technology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1198960241707679864, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, authorId=1198960241414078555, language=CN, stringName=唐煜, firstName=煜, middleName=null, lastName=唐, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.清华大学药学院, 清华大学药学技术中心, 北京 100084, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1198960239337898869, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, xref=null, ext=[AuthorCompanyExt(id=1198960239346287480, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239337898869, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1. Center of Pharmaceutical Technology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China), AuthorCompanyExt(id=1198960239371453306, tenantId=1146029695717560320, journalId=1189982191388893191, articleId=1198656215766102871, companyId=1198960239337898869, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.清华大学药学院, 清华大学药学技术中心, 北京 100084)])])]
田国芳1, 薛岚2, 刘曦2, 裴欢2, 唐煜1, *
作者信息
  • 1.清华大学药学院, 清华大学药学技术中心, 北京 100084
  • 2.北京北大维信生物科技有限公司, 北京 100083
通讯作者:
*唐煜, Tel: 86-10-62795450, E-mail:
Rapid identification of chemical constituents in Xuezhikang Capsule by UPLC-Q-TOF/MSE combined with the establishment of UNIFI MS database
Guo-fang TIAN1, Lan XUE2, Xi LIU2, Huan PEI2, Yu TANG1, *
Affiliations
  • 1. Center of Pharmaceutical Technology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China
  • 2. Beijing WBL Peking University Biotechnology Co., Ltd., Beijing 100083, China
出版时间: 2023-10-12 doi: 10.16438/j.0513-4870.2023-0008
文章导航
收藏切换

本研究采用UPLC-Q-TOF/MSE技术结合UNIFI数据库开发了快速、全面、准确、高效的血脂康胶囊化学成分定性分析方法。利用化合物名称、分子量、分子式、结构式等信息建立UNIFI数据库, 并依据高分辨质量数、同位素分布、质量偏差、碎片离子匹配度、色谱保留行为等信息进行数据库自动检索, 实现药材和制剂中天然产物的定性鉴定。结合手动确证, 在血脂康胶囊及红曲药材中鉴定到82种化学成分, 对于其中的有机酸类、黄酮类、莫纳克林类、红曲色素类主要成分进行了质谱裂解规律分析, 确保鉴定准确度, 多种莫纳可林类化合物为首次采用LC-MS工作流程实现定性分析。综上, 本研究通过LC-MS技术阐明了血脂康胶囊的化学物质基础, 为血脂康胶囊中药制造过程中的关键质量属性控制和一致性评价提供了扎实的实验数据支持, 为基于血脂康胶囊的药效物质基础研究提供支撑。

UPLC-Q-TOF  /  MSE  /  UNIFI数据库  /  血脂康胶囊  /  分析方法开发

An UPLC-Q-TOF/MSE technology coupled with UNIFI database was used to develop a rapid, high coverage, accurate and efficient chemical composition qualitative method for Xuezhikang Capsule. A UNIFI database was established utilizing compound name, formula, structure, following automatic matching with high-resolution mass numbers, isotope distributions, mass deviations, fragment ion matching, and chromatographic retention features in UNIFI database to achieve the qualitative results of natural products in Xuezhikang Capsules. Combined with manual confirmation, 82 chemical components were identified in Xuezhikang Capsules, and the MS2 fragmentation pathway of typical organic acids, flavonoids, monacrines, and monascus were analyzed to ensure accuracy of the LC-MS workflow. This study clarified the chemical substance basis of Xuezhikang Capsules by LC-MS technology, providing experimental data support for the identification of key quality attributes, quality control and consistency evaluation in the manufacturing process of Xuezhikang Capsules.

UPLC-Q-TOF  /  MSE  /  UNIFI database  /  Xuezhikang Capsule  /  analytical method development
田国芳, 薛岚, 刘曦, 裴欢, 唐煜. 基于UPLC-Q-TOF/MSE的UNIFI质谱数据库建立及其在血脂康胶囊化学成分的快速分析中的应用. 药学学报, 2023 , 58 (10) : 2862 -2874 . DOI: 10.16438/j.0513-4870.2023-0008
Guo-fang TIAN, Lan XUE, Xi LIU, Huan PEI, Yu TANG. Rapid identification of chemical constituents in Xuezhikang Capsule by UPLC-Q-TOF/MSE combined with the establishment of UNIFI MS database[J]. Acta Pharmaceutica Sinica, 2023 , 58 (10) : 2862 -2874 . DOI: 10.16438/j.0513-4870.2023-0008
血脂康胶囊是以特制红曲为原料提取浓缩制成的中成药, 富含多种天然复合他汀类成分, 被誉为天然他汀[1]。血脂康胶囊具有化浊降脂、活血化瘀、健脾消食之功效[2], 广泛应用于治疗高脂血症、脂肪肝、动脉粥样硬化、高血压、冠心病、肾病综合征等, 其疗效确切、不良反应少, 受到临床重视[3-5]。循证医学临床研究证明, 血脂康可以明显减少冠心病事件发生率, 降低总死亡率[6]。其有效成分有极强的抗癌活性, 能抑制MCF-7人乳腺癌以及Walder 256肉瘤细胞株的生长, 对人肝癌PLC/PRF5和KB细胞也有抑制作用[7]。此外, 还具有抗炎、抗氧化、抗补体、免疫抑制和促进血小板凝聚等活性[8, 9]。但其发挥效应的药效物质基础尚未明确, 为探究其药效物质, 对血脂康胶囊进行系统的化学物质基础研究具有必要性。
液相色谱质谱联用技术(LC-MS) 以LC作为分离系统, MS为检测系统, 体现了色谱和质谱优势的互补, 将色谱对复杂样品的高分离能力, 与MS具有高选择性、高灵敏度及能够提供相对分子质量与结构信息的优点结合起来, 在药物分析、食品分析和环境分析等许多领域得到了广泛的应用[10, 11]。其中, 超高效液相色谱四极杆飞行时间质谱(UPLC-Q-TOF) 系统配置了高分辨质量分析器, 能够获得复杂体系中各类化合物的高精度质量数及高质量碎片离子, 广泛应用于中药制剂的化合物成分鉴定研究中[12]。UNIFI科学系统是Waters公司开发的质谱数据处理系统, 该软件可自动进行特征峰提取及自动解析, 并与软件预设或用户自建的数据库中信息自动进行高分辨分子离子峰、碎片离子、保留时间、淌度值等关键信息匹配, 能够快速分析中药复方中的化学成分。解决了传统高分辨质谱处理流程中逐一手动标注化合物特征峰, 解析过程复杂且耗时较长的缺点[13-15]
本研究整理血脂康胶囊相关成分信息, 建立基于UNIFI软件的质谱数据库, 采用该数据库对血脂康胶囊的化学成分进行快速、准确地LC-MS表征, 为该制剂的中药化学成分分析及药效物质基础研究提供支持。
供试品及试剂信息  红曲药材、胶囊制剂等供试品由北京北大维信生物科技有限公司提供。红曲药材一批次, 批号为H20211210; 制剂三批次, 批号分别为20211020、20211240、20211256。选取了9种他汀类、莫纳可林类、黄酮类、甾醇类标准品进行对照, 进一步提高所建立UNIFI数据库的数据质量及鉴定结果的准确度, 包括洛伐他汀(批号100600-202006, 纯度≥ 99%)、麦角甾醇(批号111845-201604, 纯度≥ 96%)、大豆苷元(批号111502-202003, 纯度≥ 99%)、染料木素(批号111704-202104, 纯度≥ 99%) 均购自中国食品药品检定研究院; 洛伐他汀酸钠(批号4339-040A2, 纯度≥ 97%) 购自加拿大TLC公司; 莫纳可林J (批号ESS-139-24, 纯度≥ 95%)、脱氢莫纳可林K (批号ESL-029-24, 纯度≥ 99%)、美伐他汀(批号ESL-019-19, 纯度≥ 99%)、莫纳可林M (批号ONL-129-08, 纯度≥ 98%) 均购自美国AOCS公司。乙醇、甲酸、乙腈、甲醇均购自美国Thermo Fisher公司; 去离子水, 制备自MilliQ Advantage A10超纯水机; 1.5 mL离心管、15 mL离心管及进样小瓶均购自美国Axygen公司。
实验仪器  高分辨液质联用分析采用Synapt G2-Si Q-TOF超高效液相色谱串联飞行时间质谱仪和液相色谱部分型号为ACQUITY UPLC Ⅰ Class、UNIFI Portal科学信息系统和Masslynx V4.2色谱质谱工作站(美国Waters公司); Cosmosil 5C18-MS-Ⅱ (250 mm × 4.6 mm, 5 μm) 色谱柱(美国Amresco公司); Vortex-2 Genie涡旋混合器(美国Scientific Industries公司); WD-9415C超声波清洗器(北京市六一仪器厂); 5910 Ri G冷冻离心机(德国艾本德公司)。
样品制备方法  对于红曲药材样品和血脂康胶囊制剂样品, 取红曲药材或者胶囊内容物0.3 g, 精密称定, 置于15 mL离心管内, 加入10 mL 75%乙醇水溶液(乙醇-水, 75∶25), 超声10 min, 摇匀, 定容。取溶液适量, 5 000 r·min-1离心3 min后, 取上清液用0.22 μm滤膜过滤, 取滤液1 mL装入进样小瓶中, 于4 ℃避光保存, 待LC-MS分析。空白样品采用相同条件处理。
标准溶液制备, 精密称定各标准品10 mg, 分别置于10 mL量瓶中, 加入乙腈溶解、超声、混匀、定容, 配制成1 mg·mL-1标准溶液储备液, 分别取各对照品储备液适量, 依次稀释、混合后配制成2 μg·mL-1混合标准品工作液, 于4 ℃避光保存。
色谱方法  本研究采用具有高峰容量、高分辨率的UPLC-Q-TOF/MSE技术对血脂康胶囊供试品中的多种天然产物进行分析, 采用Cosmosil 5C18-MS-Ⅱ (250 mm × 4.6 mm, 5 μm) 色谱柱进行色谱分离, 流动相采用0.1%甲酸水作为A相, 含0.1%甲酸的乙腈甲醇溶液(乙腈-甲醇, 9∶1) 作为B相。梯度洗脱, 洗脱程序如下: 0~7 min, 6%~14% B; 7~15 min, 14%~33% B; 15~25 min, 33%~55% B; 25~43 min, 55%~85% B; 43~50 min, 85%~58% B; 50~55 min, 58%~6% B; 55~60 min, 6% B。流速为1 mL·min-1, 柱温为30 ℃, 进样量15 μL, 柱后分流50%后分别进行紫外256 nm和质谱检测。
质谱方法  高分辨质谱数据采集采用Synapt G2-Si Q-TOF/MS高分辨离子淌度质谱仪, 采用电喷雾电离源(ESI), 扫描模式为MSE, 在resolution mode, 正、负离子模式下分别进行样品分析。亮氨酸脑啡肽作为实时校正参比化合物, 离子源温度为125 ℃; 脱溶剂气为高纯氮气, 脱溶剂温度为400 ℃, 氮气流量为800 L·h-1; 锥孔气流速为50 L·h-1, 锥孔电压设置为40 V; 毛细管电压在正、负离子模式下分别为3 000 V (ESI+) 及2 500 V (ESI-); 碰撞能区间设置为10~50 eV; TOF质量扫描范围设置为m/z 50~1 200 Da。
UNIFI质谱数据库的建立方法及数据处理流程
化合物信息采集及整理  对血脂康胶囊及红曲化学成分相关的文献报道进行查阅和总结, 通过检索PubChem、Scifinder、Chemicalbook数据库, 如表 1所示, 获取共101种化合物的信息, 包括化合物中英文名称、分子式、分子量、结构式, 将这些信息与.mol格式化合物结构文件同时导入UNIFI数据库中。另外采用混合标准溶液直接获取了9种化合物的色谱质谱信息, 将两部分内容整合, 建立以血脂康胶囊主要成分他汀类、莫纳可林类、红曲色素类等的数据库, 结合原有中药数据库中的有机酸、黄酮、甾体、糖类等成分, 补充建立针对血脂康胶囊优化的UNIFI数据库。
LC-MS原始数据处理及特征峰提取、鉴定  将Masslynx采集的.raw格式的原始数据导入到UNIFI软件中, 对特征峰进行识别、同位素分布拟合及元素组成匹配。选择基于MSE数据的精确质量数筛查模板, 设定方法参数如下: 峰处理设置2D峰检测阈值为200, 3D峰低能量扫描阈值为500, 高能量扫描阈值为150, 应用lockmass校正, 正离子模式校正质量数为556.276 6, 负离子模式校正质量数为554.262 0; 在目标筛选设置中, 对于数据库中有保留时间的组分, 设置保留时间匹配阈值为±0.1 min, 母离子质量偏差阈值设置为±10 ppm, 从结构生成的预测碎片离子匹配容差设置为5 mDa, 保留最大碎片离子数设置为10, 将优化后数据库导入方法中, 保存为当前数据处理方法进行数据分析。
UNIFI软件会将低能通道识别到的分子离子峰与建立的数据库自动匹配, 结合高能通道匹配到的碎片离子峰自动列出最佳匹配度的物质。为了增加准确性, 选择结合色谱保留时间、精确分子质量、特征碎片离子, 同系物极性差异等理化特征进行手动确证, 同时通过对照品信息和相关文献中化合物特点的对照, 对于特征峰的可靠鉴定结果进行标记。
未知化合物进一步手动鉴定及识别  对于未能在所建立的目标数据库中匹配的且具有较高峰面积的化合物, 使用UNIFI软件中的Elucidate功能进行解析, 主要分为三个途径进行分析: ①利用UNIFI软件中自带的天然产物数据库进行检索; ②采用内嵌的ChemSpider模块进行精确分子量和分子式的在线检索; ③若前两种方式均无法给出特征峰鉴定结果, 则采用Elemental Composition模块进行同位素i-FIT评分匹配, 结合分子离子、高能通道中的特征碎片及色谱保留行为, 推断其可能的结构类型。
报告生成及结果导出  化合物鉴定结果包括名称、分子式、m/z、质量偏差、分子量、加合离子、峰面积等信息, 可直接导出至Excel中。使用UNIFI软件中的报告功能可生成鉴定结果的PDF文件, 信息包括特征峰精确质量数的提取离子流图、MS1低能谱图、MS2的高能谱图及碎片离子结构预测结果, 基于UNIFI软件提供的碎片离子结构进一步确定化合物鉴定结果。
血脂康主要成分鉴定的采集条件优化包括液相色谱条件的优化和质谱条件的优化。建立适合分离血脂康中化合物的液相方法, 优化主要化合物的分离度, 是准确定性鉴定的先决条件, 可以降低后期定性鉴定假阴性的结果。通过文献调研和前期实验条件的摸索, 如图 1所示, 研究对比了Cosmosil 5C18-MS-Ⅱ色谱柱、Waters UPLC BEH C18 (100 mm × 2.1 mm, 1.7 µm) 色谱柱、Waters UPLC HSS T3 (100 mm × 2.1 mm, 1.8 µm) 色谱柱, 最终选择了Cosmosil 5C18-MS-Ⅱ色谱柱。流动相方面, 优化了甲醇、乙腈、异丙醇等不同配比, 以及添加甲酸、乙酸、乙酸铵等不同酸、盐的流动相体系, 选择了分离度和重复性俱佳的乙腈甲醇溶液体系, 添加甲酸进一步优化分离度, 采用该方法对多批次样品进行检测。
采用建立的UNIFI数据库进行三批次血脂康胶囊和一批次红曲原料的化学成分检测, 以峰面积大于1 000, 质量偏差小于10 ppm作为筛选条件, 并且手动确认, 选取结果中与建立数据库碎片离子相匹配的成分作为阳性结果。鉴定到82种组分, 结果如表 2所示, 包括33种有机酸类化合物、24种莫纳可林类化合物、7种红曲色素类化合物、7种他汀类化合物、5种黄酮类化合物、4种糖类化合物和2种甾醇类化合物。血脂康胶囊制剂样品的正、负离子模式下的质谱基峰离子流图(BPI图) 如图 2所示, 图中序号对应表 2中各化合物序号。
红曲色素是红曲霉在生长代谢过程中产生的天然色素。血脂康胶囊中的红曲色素是多种色素成分的混合物, 主要类型为红色素, 是一种天然色素, 安全性高, 具有广泛的生物学活性, 包括抗菌、抗癌等[9], 其内源性衍生物能够抑制脂肪酶, 调节脂质代谢, 预防动脉粥样硬化, 是血脂康胶囊的主要化学成分之一。本研究中共鉴定到红曲色素类成分7种, 以化合物63为例, 其保留时间为38.33 min, 极性较弱, 在正离子模式下准分子离子峰[M+H]+ m/z为359.172 1, 匹配其分子式为C21H26O5, 质量偏差-1.5 ppm, 在二级质谱图中可见其主要碎片离子为m/z 215.122 8、187.125 4、184.085 6、159.134 2, 其主要裂解途径包括呋喃环裂解产生的m/z 215.122 8, 随后脱甲基产生m/z 187.125 4, 另一条裂解途径为呋喃环裂解产生的另外一部分碎片离子m/z 187.125 4, 随后脱甲基产生m/z 159.134 2。基于此推测其质谱裂解途径如图 3所示, 该裂解途径与UNIFI软件给出的化合物匹配结果和碎片离子结构预测结果一致, 结合其极性特征和分子式匹配结果, 推测该化合物为红曲素。
莫纳可林类化合物是红曲霉中分离提取的一类代谢物, 具有低毒性、高效力的特点[16], 其结构与HMG-CoA还原酶相似, 可以竞争性抑制该酶参与胆固醇合成, 从内源性代谢途径上减少胆固醇, 从而达到降低血脂的目的[2, 17]。与洛伐他汀相比, 以莫纳可林K为代表的莫纳可林类化合物生物利用度更高、降胆固醇效率更高、不良反应更少, 是血脂康胶囊发挥降血脂效果的主要药理成分。本研究中鉴定到莫纳可林及其代谢物共24种, 以特征峰75为例, 其保留时间为44 min, 极性较小, 在正离子模式下准分子离子峰m/z为409.224 4, 属加钠峰, 匹配其分子式为C24H34O4, 质量偏差0.1 ppm, 在二级质谱图中可见其主要碎片离子为m/z 307.175 5、207.129 1、155.100 6、143.101 3, 其主要裂解途径包括C环裂解重排的逆狄尔斯-阿德尔(RDA) 反应产生m/z 307.175 5、207.129 1, 随后进一步脱烷基形成m/z 155.100 6、143.101 3, 基于此推测其质谱裂解途径如图 4所示, 该裂解途径与UNIFI软件给出的化合物匹配结果和碎片离子结构预测结果一致, 结合其极性特征和分子式匹配结果, 推测该化合物为脱氢莫纳可林K。
黄酮类化合物是广泛存在于自然界植物中的一类化合物, 属于植物的次生代谢产物。具有抗自由基、抗氧化、提高机体免疫力以及抗炎镇痛的作用[18]。本研究中鉴定到5种黄酮类化合物, 以特征峰40为例: 其保留时间为23.27 min, 极性中等, 在正离子模式下准分子离子峰[M+H]+ m/z为271.072 8, 匹配其分子式为C15H11O5, 质量偏差0 ppm, 在二级质谱图中可见其主要碎片离子为m/z 253.064 6、243.079 4、215.084 4、153.035 7、91.069 9, 其中m/z 253.064 6为黄酮苷元典型的脱水产生的碎片离子, 而m/z 243.079 4、215.084 4、153.035 7则为RDA反应产生的碎片离子, 经过进一步开环重排产生m/z 91.069 9, 基于此推测其质谱裂解途径如图 5所示, 符合文献[19]报道的黄酮类化合物的质谱裂解规律。参考UNIFI软件给出的化合物匹配结果和碎片离子结构预测, 结合标准品保留时间的进一步手动确证, 推测该化合物为染料木素。
天然有机酸类化合物广泛分布于自然界植物中, 主要包括脂肪族有机酸和芳香族有机酸两大类, 常见的有柠檬酸、绿原酸、原儿茶酸、齐墩果酸等, 具有抗菌、抗炎、抗氧化等多种生理学活性[20]。本研究中鉴定到33种有机酸类化合物, 其在血脂康胶囊中分布广泛, 来源多样, 是构成血脂康胶囊药理学活性的重要部分。以特征峰13为例: 其保留时间为4.14 min, 极性高, 在负离子模式下准分子离子峰[M-H]- m/z为191.019 7, 具有典型的极性有机酸色谱质谱特征, 匹配其分子式为C6H8O7, 质量偏差0.3 ppm, 在二级质谱图中可见其主要碎片离子为m/z 173.007 7、111.008 3、96.957 3、m/z 87.006 1, 其中m/z 173.007 7为典型的有机酸脱水产生的碎片离子, 随后进一步发生脱甲基、脱羧基等反应产生其他碎片离子, 基于此推测其质谱裂解途径如图 6所示, 符合文献[21]报道的有机酸类化合物质谱裂解规律。参考UNIFI软件给出的化合物匹配结果和碎片离子结构预测, 推测该化合物为柠檬酸。
他汀类化合物能抑制内源性胆固醇合成, 降低包括总胆固醇、甘油三酯、低密度脂蛋白和高密度脂蛋白的血清水平[22], 是血脂康胶囊发挥抗高脂血症和动脉粥样硬化引起的心血管疾病治疗的主要药效成分之一, 常作为血脂康胶囊的主要质控成分。以特征峰58为例: 其保留时间为35.38 min, 极性较小, 在负离子模式下准分子离子峰[M-H]- m/z为421.264 0, 匹配其分子式为C24H38O6, 质量偏差-0.5 ppm, 在二级质谱图中可见其主要碎片离子为m/z 319.187 0、101.060 5、85.029 0, 其中m/z 319.187 0及m/z 101.060 5为脱酯基产生的两部分主要碎片离子, m/z 319.187 0随后产生多氢萘环断裂形成m/z 85.029 0。基于此推测其质谱裂解途径如图 7所示, 参考UNIFI软件给出的化合物匹配结果和碎片离子结构预测, 推测该化合物为洛伐他汀酸。
传统中药制剂化学物质基础复杂, 手动对质谱原始数据进行处理费时费力, 难以挖掘有用的信息。本研究采用UNIFI进行了血脂康胶囊的全面、快速、准确、高效的LC-MS数据分析和天然产物成分的鉴定工作, 基于所建立的UHPLC-ESI-QTOF/MSE分析方法, 整合自建UNIFI数据库, 在多批次血脂康胶囊和红曲原料中鉴定到82种组分, 包括33种有机酸类化合物、24种莫纳可林类化合物、7种红曲色素类化合物、7种他汀类化合物、5种黄酮类化合物、4种糖类化合物和2种甾醇类化合物, 对于核心种类化合物采用质谱碎裂途径分析验证了该UNIFI软件工作流程的可行性和准确性, 其中多种莫纳可林类化合物为首次采用LC-MS工作流程实现鉴定。在鉴定到的化合物中, 莫纳克林类化合物主要发挥降血脂作用[17], 红曲色素类则具有抗高血压、冠心病、糖尿病、动脉粥样硬化等生理学活性[9], 而同时检测到的黄酮、有机酸等化合物则发挥着抗菌、抗炎、抗氧化等功能[18, 20], 充分印证了传统中药制剂多组分协同作用的药理学机制。首次通过LC-MS技术细致分析并阐明了血脂康胶囊的化学物质基础, 在化合物覆盖范围、测试准确度、工作流程自动化等方面显著优于现有方法[16, 22-24]。本研究为基于网络药理学的关键质量属性辨识提供了实验基础, 为血脂康胶囊的关键质量属性控制和一致性评价提供扎实的数据支持, 为基于血脂康胶囊的药效物质基础研究和基于红曲的安全性研究等提供支撑。
在实验技术方面, 由于本研究采用的基于UNIFI软件自建数据库和检索的工作流程仍无法在没有标准品的情况下准确区分同分异构体特征峰归属, 对于莫纳可林类同分异构体, 本研究通过标准品的保留时间标定其中一种化合物, 如莫纳可林M, 进而将其他保留时间位置的特征峰标记为莫纳可林M的同分异构体二氢莫纳可林K。但对于部分有机酸, 如绿原酸、熊果酸等, 其同分异构体在该色谱体系中难以产生有效的基线分离, 因此只能通过优化质谱方法, 得到更丰富的碎片离子进行解析, 并尝试通过离子淌度技术对同分异构体实现基线分离, 但目前该设备开启离子淌度后的数据采集仍存在降低分析灵敏度, 丢失低丰度信息等核心技术难题, 需要在今后的研究中进一步优化方法, 实现同分异构体的解析和验证, 更好地为中药制造全流程提供质量控制支持。
作者贡献: 田国芳负责数据库构建、样品测试及文章撰写; 薛岚负责样品制备及文献查询; 刘曦负责课题监管及文章修改; 裴欢负责样品制备; 唐煜负责课题监管、文章撰写、文章审阅及技术指导。
利益冲突: 本文中所有作者声明无任何利益冲突。
  • 清华大学实验室创新基金
参考文献 引证文献
排序方式:
[1]
Li XM , Shen XH , Duan ZW , et al . A new monacolin analogue from Xuezhikang Capsule[J]. Acta Pharm Sin (药学学报), 2011, 46: 564-567.
[2]
Ma XM , Guo SR , Duan ZW , et al . Chemical constituents of Xuezhikang Capsula[J]. Chin Tradit Herb Drugs (中草药), 2007, 38: 650-652.
[3]
Li J , Zhu Y , Wang K . Clinical study on Xuezhikang Capsules combined with pravastatin in treatment of chronic heart failure[J]. Drugs Clin (现代药物与临床), 2022, 37: 2276-2280.
[4]
Meng TT , Xie XL , Li TT , et al . Oral Chinese patent medicine combined with statins in treatment of dyslipidemia: a network meta-analysis[J]. Chin Tradit Herb Drugs (中草药), 2021, 52: 1092-1104.
[5]
Ye F , Yu ZH , Yang JH , et al . Effect of Xuezhikang Capsule in treatment of coronary heart disease and its influence on vascular endothelial function and heart function[J]. Chin Arch Tradit Chin Med (中华中医药学刊), 2022, 40: 180-183.
[6]
Zhou K , Ding BH . Clinical observation on Xuezhikang Capsule for 116 cases of coronary heart disease with abnormal blood lipid[J]. J Tradit Chin Med (中医杂志), 2007, 48: 992-993.
[7]
Yang Z , Zhao JX , Zhang YG . Anti-neoplastic effect of Xuezhikang in vitro[J]. J Tradit Chin Med (中医杂志), 2008, 49: 1019-1022.
[8]
Li B , Hu SY , Wu X , et al . Anti-oxidant and anti-inflammatory effects of Xuezhikang capsule on patients with coronary heart diseases[J]. Prog Mod Biomed (现代生物医学进展), 2011, 11: 2289-2291.
[9]
Jiang YQ , Dong YJ , Zhou FJ , et al . Research progress on chemical constituents, pharmacological action and clinical application of Fermentum Rubrum[J]. Chin Tradit Herb Drugs (中草药), 2021, 52: 7379-7388.
[10]
Tang Y , Zhang JL . Recent developments in DNA adduct analysis using liquid chromatography coupled with mass spectrometry[J]. J Sep Sci, 2020, 43: 31-55.
[11]
Ji H , Xu Y , Lu H , et al . Deep MS/MS-aided structural-similarity scoring for unknown metabolite identification[J]. Anal Chem, 2019, 91: 5629-5637.
[12]
Tang Y , Chen X , Wang D , et al . Discover and identify unknown alkylation DNA adducts induced by sulfonates using prediction driven-MRM-profiling strategy[J]. Talanta, 2021, 222: 121500.
[13]
Yuan FL , Liu CX , Wang Q , et al . Rapid detection and identification of compounds in Jiuwei Zhenxin Granules based on UPLC-Q-TOF/MSE and UNIFI software[J]. Drug Eval Res (药物评价研究), 2020, 43: 1997-2008.
[14]
Wang ML , Zhang QQ , Fu S , et al . Characterization of Morinda officinalis How. by UPLC-Q-TOF MSE coupled with UNIFI database filter[J]. J Chin Mass Spectrom Soc (质谱学报), 2017, 38: 75-82.
[15]
Wu H , Tang MX , Tao XY , et al . Rapid identification of chemical consituents in cinobufacini injection by UPLC-ESI-QTOF/MSE combined with UNIFI informatics platform[J]. Nat Prod Res Dev (天然产物研究与开发), 2020, 32: 498-506.
[16]
Li YG , Zhang F , Wang ZT , et al . Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry[J]. J Pharm Biomed Anal, 2004, 35: 1101-1112.
[17]
Li XM , Shen XH , Duan ZW , et al . Advances in studies on secondary metabolites from Monascus[J]. Chin Tradit Herb Drugs (中草药), 2011, 42: 1018-1025.
[18]
Li XP , Yu MX , Kuang RT , et al . Research progress on the anti-tumor effect of flavonoid derivatives[J]. Acta Pharm Sin (药学学报), 2021, 56: 913-923.
[19]
Ding YT , Zheng ZH , Zhao RY , et al . Rapid identification of chemical constituents in Psoralea coryifolia by UPLC-Q-TOF-MSE combined with UNIFI informatics platform[J]. J Chin Mass Spectrom Soc (质谱学报), 2018, 39: 729-745.
[20]
Yu S , Zhang L , Shan MQ , et al . Simultaneous determination of eight organic acids in Chaenomelis Fructus by UFLC-MS[J]. Chin Tradit Herb Drugs (中草药), 2016, 47: 2465-2469.
[21]
Wang YC , Dong JX , Li JG , et al . Rapid analysis of chemical components of Wenjing Decoction Standard Decoction based on UPLC-Q-TOF/MS technology combined with UNIFI database[J]. J Shenyang Pharm Univ (沈阳药科大学学报), 2022, 39: 639-652.
[22]
Li XM , Xue L , Fu P , et al . Determination of lovastatin and lovastatin acid in Xuezhikang Capsules by HPLC[J]. China Pharm (中国药师), 2012, 15: 164-166.
[23]
Li Y , Sun X . Simultaneous content determination of 8 components in Xuezhikang Capsules by HPLC-DAD[J]. China Pharm (中国药房), 2019, 30: 2066-2070.
[24]
Tu WQ , Zhang LJ , Xu ZZ . Simultaneous determination of three constituents in Yixin Xuezhikang Capsules by HPLC[J]. Chin Tradit Pat Med (中成药), 2017, 39: 316-319.
2023年第58卷第10期
PDF下载
535
251
引用本文
BibTeX
文章信息
doi: 10.16438/j.0513-4870.2023-0008
  • 接收时间:2023-01-05
  • 首发时间:2025-11-21
  • 出版时间:2023-10-12
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-01-05
  • 修回日期:2023-04-04
基金
清华大学实验室创新基金
作者信息
    1.清华大学药学院, 清华大学药学技术中心, 北京 100084
    2.北京北大维信生物科技有限公司, 北京 100083

通讯作者:

*唐煜, Tel: 86-10-62795450, E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/yxxb/CN/10.16438/j.0513-4870.2023-0008
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏